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ABSTRACT
PEROXYGENASE ACTIVITY OF CYTOCHROME c PEROXIDASE

Heather Kilheeney, M.S.
Department of Chemistry and Biochemistry
Northern Illinois University, 2016
James E. Erman, Director
Heme enzymes catalyze the oxidation of a wide variety of substrates utilizing either
molecular oxygen or hydrogen peroxide as oxidants. There is some interest in utilizing heme
enzymes in the synthetic laboratory to introduce oxygen functionalities into organic structures
due to their specificity and low levels of side reactions. The most versatile oxygenation catalysts
are a group of monooxygenases called the cytochrome P450s. However, the cytochrome P450s
are not ideal synthetic catalysts since the monooxygenase reaction is quite complex, requiring a
co-factor, either NADH or NADPH, and an additional enzyme called P450 reductase.

In

addition, the cytochrome P450 reactions are typically slow and the enzymes prone to oxidative
degradation.
Attention has been given to the peroxygenase activity of heme proteins, the incorporation
of an oxygen atom from hydrogen peroxide into an organic substrate.

The peroxygenase

reaction eliminates the need for NADH or NADPH and the P450 reductase.

Although

peroxygenation is not a typical reaction catalyzed by heme enzymes, many heme proteins have
low levels of peroxygenase activity. This thesis explores the peroxygenase activity of the wellstudied heme protein, cytochrome c peroxidase (CcP).

CcP is an ideal candidate for exploring the peroxygenase activity of heme proteins and
for the development of robust peroxygenation catalysts since it reacts rapidly with hydrogen
peroxide and is very stable toward oxidative degradation. Protein engineering studies allow us to
enhance the peroxygenase activity of CcP by creating a more apolar environment to facilitate the
binding of organic substrates near the heme.
Three CcP mutants with apolar heme pockets were constructed by converting Arg48,
Trp51, and His52 simultaneously to all alanines (CcP(triAla)), all valines (CcP(triVal)), or all
leucines

(CcP(triLeu)).

Styrene

and

acrylonitrile

epoxidation

reactions

and

1-

methoxynaphthalene hydroxylation reactions were studied using wild-type CcP and CcP mutants
to investigate the peroxygenase activity of these enzymes. CcP Compound I oxidizes styrene
and acrylonitrile with observed bimolecular rate constants of (4.6 ± 4.1) x 10-4 M-1 s-1 and (4.3 
0.3) x 10-3 M-1 s-1, respectively. The rate of the peroxygenation of acrylonitrile catalyzed by CcP
is similar to that of the monooxygenase oxidation reaction of acrylonitrile catalyzed by rat liver
microsomal P450. The CcP triple mutants hydroxylate 1-methoxynapthalene at rates that are
about 30 times faster than wild-type CcP. However, the turnover rates of 0.13 to 0.15 min-1 are
small when compared with the 103 min-1 rates of the monoxygenase activity of some bacterial
P450s.
A fourth CcP mutant, meant to mimic the heme coordination of cytochrome P450,
CcP(H175C/D235L), had a smaller rate of naphthalene hydroxylation than the CcP triple
mutants. Unfortunately, all of the CcP mutants had increased rates of heme degradation during
the hydroxylation reaction compared to wild-type CcP. Further development of CcP as a
peroxygenation catalyst will need to focus on the stability of the enzyme as well as increasing the
rate of substrate turnover.
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CHAPTER ONE
INTRODUCTION

Protein molecules, known as enzymes, catalyze essentially all of the metabolic reactions
in living organisms. Enzymes catalyze these reactions under the ambient conditions of the
organism, with great specificity, and with rates sufficient to maintain life processes. Chemists
have been intrigued by the catalytic properties of enzymes and many have sought to either
emulate the properties of enzymes or to use specific enzymes themselves in synthetic chemical
reactions. Heme enzymes are ubiquitous in nature and catalyze a wide variety of oxidation
reactions utilizing either molecular oxygen or hydrogen peroxide as the oxidant. Some heme
enzymes have been used in the synthetic laboratory to catalyze specific oxidation reactions [1,
2]. Unfortunately, under conditions used in chemical synthesis, many heme enzymes are not
stable and require expensive co-factors to catalyze the reaction. With the development of
recombinant DNA techniques and the ability to modify protein structure through site-directed
mutagenesis, many attempts have been made to optimize the properties of enzymes for use as
catalysts in organic synthesis [3, 4].

This thesis will explore the properties of two heme

enzymes, cytochrome P450 and cytochrome c peroxidase, as well as a number of cytochrome c
peroxidase mutants to provide a better understanding of their peroxygenase activity and possibly
to increase their potential use in chemical synthesis.
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Heme Proteins

Biological systems utilize heme proteins for their survival. Heme proteins perform many
essential functions that can be organized into four main groups: (1) oxygen transport and
storage, (2) electron transfer, (3) heme sensors and (4) catalysis of redox reactions. The latter
group catalyzes the oxidation of various organic and inorganic compounds using either
molecular oxygen or hydrogen peroxide [5].
The catalytic center of a heme enzyme is the heme group. The various functions of heme
proteins are determined by changes in chemical behavior of the heme when it interacts with
different proteins. Heme is generally understood as any tetrapyrollic chelate of iron, with the
most common heme a coordination complex of an iron atom and protoporphyrin IX.
Protoporphyrin IX is composed of four pyrrole rings joined by methine bridges with methyl
substitutions at positions 1, 3, 5, and 8 of the porphyrin ring, vinyl substitutions at positions 2
and 4, and propionate side chains at positions 6 and 7. The carbon atoms of the methine bridges
are labelled α, β, γ, δ. The complete name of protoporphyrin IX is 1,3,5,8-tetramethyl-2,4divinylporphine-6,7-dipropionic acid [6]. Coordination of an iron ion to protoporphyrin IX
produces the complex known as heme b. Heme b is shown in Figure 1.1.
Hemes a and c are common derivatives of heme b. In heme a, found in cytochrome c
oxidase, the vinyl group at position 2 is substituted with a farnesyl group and the methyl at
position 8 is replaced by a formyl group. In heme c, found in cytochrome c, the vinyl groups at
positions 2 and 4 form covalent thioether linkages with cysteine residues in the protein. Less
common hemes include heme d found in bacteria and heme l found in lactoperoxidase.
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Figure 1.1: Structure of Heme b (ferriprotoporphrin IX).

Heme enzymes generally catalyze oxidation-reduction reactions utilizing either molecular
oxygen or hydrogen peroxide as the oxidizing agent. Three major classes of heme enzymes
utilize molecular oxygen. The oxidases oxidize substrates while reducing molecular oxygen to
two molecules of water. The dioxygenases incorporate both atoms of molecular oxygen into an
organic substrate, while the monooxygenases incorporate one oxygen atom into an oxidizable
substrate and reduce the second oxygen atom to water. Two major classes of heme enzymes
utilize hydrogen peroxide as substrate, the peroxidases and the catalases.

Peroxidases use

hydrogen peroxide to oxidize a wide variety of organic and inorganic substrates while reducing
hydrogen peroxide to water. The catalases disproportionate hydrogen peroxide into water and
molecular oxygen. Many of the heme enzymes utilize heme b and their differential reactivity
depends upon the nature of the protein including protein-heme and protein-substrate interactions.
The work described in this thesis involves a comparison of the properties of a group of
monooxygenases known as the cytochrome P450s (P450) and the peroxidases, in particular
cytochrome c peroxidase (CcP).
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Monooxygenases/P450

Monooxygenases abstract an oxygen atom from molecular oxygen to oxidize various
organic and inorganic substrates including metabolites and xenobiotics [7]. The P450’s are a
large superfamily of metabolizing monooxygenase enzymes.

Garfield and Klingenberg

discovered P450 monooxygenases in liver microsomes in 1957 [8, 9]. However, it was not until
1963 that the name cytochrome P450 was applied to this group of enzymes. The name is derived
from the unusual position of the absorption band in the reduced carbon monoxide complex,
which occurs near 450nm [10]. The unusual absorption band was later attributed to the axial
ligation of the heme b in the P450s when it was found that the heme was coordinated to the
protein through the S atom of a proximal cysteine residue. The structure of cytochrome P450CAM
is shown in Figure 1.2 [11]. In the resting state, P450’s contain iron(III) protoporphyrin IX, like
the peroxidases [6].

Figure 1.2: P450CAM structure with heme active site.
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P450’s are a versatile class of heme enzymes present in many species including plants,
fungi, bacteria, insects and mammals [12]. In mammals, the P450s aid in metabolism of many
compounds and steroid hormone biosynthesis. Other activities of P450s include hydrocarbon
hydroxylation, olefin epoxidation, heteroatom oxygenation, dealkylation of ethers, thioethers,
and substituted amines, desaturation at isolated carbon-carbon bonds and aldehyde deformylation
[13]. Due to the abundance of activities, multiple P450s can be found in the same organism.
The most common P450 function uses reducing equivalents from NADPH or NADH and
oxidizing equivalents from molecular oxygen to catalyze a variety of oxidative reactions, called
monooxygenase reactions, as shown in Equation 1.1.

NADPH + H+ + O2 + RH  ROH + H2O + NADP+

(1.1)

P450

The product will not always be a simple alcohol due to rearrangement after the initial
product is formed. The complete catalytic mechanism of P450’s is not completely understood.
A proposed catalytic mechanism is shown in Figure 1.3, with hypothetical intermediate species
in brackets.
In the first step of the mechanism (upper right-hand corner), an enzyme-substrate
complex is formed when the oxidizable substrate, RH, binds to the Fe(III) enzyme. In the
second step, one electron is transferred to the enzyme-substrate complex from NAD(P)H via
P450 reductase reducing the heme iron to the Fe(II) state. Molecular oxygen then enters the
cycle and binds to the now reduced enzyme substrate complex.

In the fourth and rate-

determining step a second electron is transferred to the heme iron-porphyrin complex from
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NAD(P)H via P450 reductase forming the Fe(II) superoxide complex. The enzyme then splits
the oxygen-oxygen bond reducing one oxygen atom to water and retaining the second oxygen
atom as an oxyferryl heme group, forming a Compound I-type intermediate. The Compound Itype intermediate abstracts a hydrogen atom from the substrate forming a Compound II-type
intermediate with a bound substrate radical. Finally, the substrate radical reacts with the oxo
oxygen in the Compound II-like intermediate producing the hydroxylated product and the P450
is returned to its native Fe(III) state [7]. Cytochrome P450 catalyzed reaction rates are generally
slow.

Hydroxylation turnover rates of liver microsomal P450s are approximately 1 min -1.

Bacterial cytochrome P450s tend to have faster rates for their specific substrates, on the order of
103 min-1 [1, 14, 15].

Figure 1.3: Hypothetical P450 mechanism.
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P450’s are important in both biological function and chemical synthesis [16]. They are
used in synthetic reactions because they insert oxygen functionalities into a wide variety of
organic substrates with high degrees of selectivity [1, 2]. However, the P450’s are not ideal
synthetic catalysts because they require NADPH or NADH, both of which are expensive
reagents.

They also generally have low turnover rates and are susceptible to oxidative

degradation during the catalytic cycle.
Cytochrome P450 can react with hydrogen peroxide to oxygenate substrates.

This

reaction excludes need for the NAD(P)H cofactor which improves using the P450s for synthetic
catalysts. This reaction is called the “peroxide shunt” pathway [2], Equation 1.2.

S + H2O2 → SO + H2O
P450

(1.2)

In the peroxide shunt pathway, hydrogen peroxide reacts with the Fe(III) state of the
heme iron to generate Compound I and a molecule of water. Compound I transfers the oxo
oxygen directly to the organic substrate, which must be in close proximity to the heme. This
pathway is generally much slower than the monoxygenase activity of the enzyme. In order to
enhance the “peroxygenase” activity of the cytochrome P450s protein engineering approaches
have been used [3]. Other studies have incorporated peroxygenase activity into other heme
proteins such as myoglobin and the peroxidases [4, 17].

Recently, naturally occurring

peroxygenases with high rates of activity have been discovered [18, 19]. This study focuses on
the “peroxygenase” activity of the heme protein, cytochrome c peroxidase.
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Cytochrome c Peroxidase

Another b-type heme protein, discovered in baker’s yeast in 1940, is cytochrome c
peroxidase, CcP [20]. CcP holds a unique place in the study of the relationship between
structure and function in the heme proteins since it was the first heme enzyme to have its threedimensional structure determined by x-ray crystallography [6].

CcP consists of a single

polypeptide chain of 294 amino acid residues, with a molecular weight of 34,200 daltons. The
heme moiety is non-covalently bound within the interior of the protein, with the iron atom
coordinated to the imidazole nitrogen of His-175. The ribbon structure of CcP is shown in
Figure 1.4.

Figure 1.4: CcP ribbon structure.
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CcP is found in the mitochondria of baker’s yeast [6]. Its’ presumed function is to
protect the cell from the deleterious effects of hydrogen peroxide, which is accomplished by the
reduction of hydrogen peroxide to water using two molecules of ferrocytochrome c. The overall
net reaction catalyzed by the enzyme is shown in Equation 1.3. C2+ and C3+ represent ferro- and
ferricytochrome c, respectively.

2C2+ + H2O2 + 2H+  2C3+ + 2H2O
CcP

(1.3)

The catalytic mechanism, as with that of the P450s, is not completely understood [5]. The
overall proposed mechanism is shown in Figure 1.5.

H2 O2
Fe3+

H2 O

Fe4+

O
H 2O

C3+
C

R*

H+

2+

H+
O

Fe4+
C

IIF

3+

H+

C2+

H 2O
H+
C3+

C2+
C3+

Fe3+
C2+
IIR
R

*

Figure 1.5: Mechanism of CcP.
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In the first step of the catalytic mechanism (Equation 1.4), CcP in its native Fe(III) state,
is oxidized to the intermediate called Compound I, CcPI, by hydrogen peroxide.

CcP + H2O2  CcPI + H2O

(1.4)

Compound I is oxidized two equivalents above the native state. The two oxidized sites are
present as an oxyferryl Fe(IV) heme and a Trp-191 radical. Then, Compound I binds with
ferrocytochrome c forming a heterodimer. Electron transfer between these two proteins results
in the oxidation of ferrocytochrome c to ferricytochrome c and the reduction of Compound I to
Compound II, CcPII, as shown in Equation 1.5.

CcPI + C2+ + H+  CcPII + C3+

(1.5)

The second intermediate is oxidized one equivalent above the native state. CcPII can
exist in two forms depending upon the site that is reduced first. If the Fe(IV) site is reduced to
Fe(III), the radical site remains in Compound II and Compound II is referred to as Compound
IIR, where the ‘R’ indicates that the radical site is present in this intermediate. If the Trp-191
radical is reduced initially, leaving the Fe(IV) site intact, then Compound II is referred to as
Compound ПF, where the ‘F’ indicates the Fe(IV) site remains.
The last redox step in the mechanism (Equation 1.6) involves Compound II binding with
a second molecule of ferrocytochrome c, forming a heterodimer in which Compound II is
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reduced back to the native state of the enzyme while producing ferricytochrome c and water.
Steps 2 and 3 in the mechanism are irreversible processes.

CcPII + C2+ + H+  CcP + C3+ + H2O

(1.6)

CcP has properties which make it a good candidate to serve as a scaffold to develop
peroxygenation catalysts through protein engineering. CcP has an observed turnover rate of
7000 s-1 [21]. The intermediate, Compound I, is very stable and the enzyme is resistant to
oxidative degradation by excess H2O2.

Peroxygenase Activity

Peroxygenase activity is the incorporation of an oxygen atom from hydrogen peroxide
into an oxidizable substrate. In the peroxygenase reaction, Equation 1.7, hydrogen peroxide
replaces the molecular oxygen, NAD(P)H, and the reductase system of the monoxygenase
reaction.

H2O2 + RH  ROH + H2O

(1.7)

The mechanism is the same as the monooxygenase mechanism except that the oxygen
molecule and the associated NAD(P)H reductase system is replaced with hydrogen peroxide
(Figure 1.3).
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There is interest in the peroxygenase activity of heme enzymes for synthetic purposes
since it simplifies the reaction conditions for oxygenation-type reactions such as substrate
hydroxylations and epoxidations. Protein engineering approaches have been used to incorporate
peroxygenase activity into the peroxidases. Ortiz de Montellano and colleagues have reported
that recombinant CcP and a W51A mutant of CcP can epoxidize both styrene and βmethylstyrene in the presence of H2O2 [22]. They reveal the turnover number for the oxidation
of trans-β-methylstyrene as 12 pmol/min/nmol enzyme and for cis-β-methylstyrene as between 3
and 7 pmol/min/nmol CcP depending on the product formed. Their findings conclude that CcP
can catalyze the epoxidation of styrene by hydrogen peroxide at a rate that is only about 10 times
slower than the monooxygenase reaction of cytochrome P450.
In an initial attempt to convert CcP into a P450, Lu and coworkers engineered a
H175C/D235L CcP double mutant to create a ferric P450 model [16].

Spectroscopic

characterization of the CcP double mutant showed that the addition of imidazole and cyanide
ligands formed hexacoordinate heme species analogous to those of P450s.
Myoglobin (Mb), another heme protein, has been previously studied for peroxygenation
reactions [23, 24].

Wild-type myoglobins can catalyze the epoxidation of styrene with a

hydrogen-peroxide dependent reaction that differs from the heme-mediated monooxygenase
reactions of cytochrome P450’s. The styrene epoxidation reaction of myoglobin occurs through
a co-oxidation mechanism that uses a polypeptide radical at the proteins surface to incorporate an
oxygen atom from molecular oxygen. A Compound I-type intermediate has never been observed
for wild-type myoglobin. Watanabe and colleagues engineered F43H/H64L Mb in order to alter
the active site of myoglobin to one similar to CcP [23]. They reported that this mutant oxidizes
styrene 300 times faster than wild-type Mb and this was the first time a compound I type
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intermediate was identified in myoglobin.

Watanabe and colleagues later created another

myoglobin mutant this time replacing the distal heme pocket histidine residue [24]. The H64D
Mb mutant yielded 600-800 fold higher peroxygenation activity than wild-type myoglobins. The
higher activity is attributed to the enhanced stability and formation rate of a Compound I type
intermediate. Because the histidine at position 64 is located very close to the heme and rapidly
reduces, Compound I formation isn’t observed. Replacing the histidine with aspartate creates a
polar heme pocket which may increase the affinity of hydrogen peroxide to the pocket.
Hydrogen peroxide may then hydrogen bond with the aspartate residue in close proximity to the
heme. When reacting the H64D Mb mutant with styrene, they report a bimolecular rate constant
of 2.1 x 104 M-1s-1. They found that 95% of the oxygen in the styrene oxide product comes from
the hydrogen peroxide by using 18O-labeled hydrogen peroxide.
Investigating the peroxygenase activity of CcP and various CcP mutants will lead to
greater understanding of this enzyme. Due to CcPs rapid reaction with hydrogen peroxide, the
stability of CcP Compound I, and its resistance to oxidative degradation, CcP may be an ideal
peroxygenase enzyme.

If robust peroxygenation catalysts can be developed, they will be

preferable to the monoxygenases in synthetic organic chemistry due to the lack of requirements
for the NAD(P)H cofactors.

Active Sites

Both cytochrome P450cam and CcP contain a single heme b at their respective active sites
but the two enzymes carry out very different reactions. Part of the difference in reactivity can be
understood based on the protein-heme interactions and the details of the active sites in the two
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enzymes. The heme of CcP is buried inside the molecule between two domains; an N-terminal
domain above the heme and a C-terminal domain below the heme (Figure 1.4). Two antiparallel helices from each domain form a crevice where the heme is located and provide a small
H2O2-access channel about 5 Å in diameter. This channel leads from the surface of the protein to
the distal heme face. Small exogenous ligands and hydrogen peroxide can diffuse through this
channel to interact with the heme iron [7]. His175 and Asp235 are located in the C-terminal
domain and are part of the proximal heme pocket. His175 is coordinated to the heme and is
hydrogen bonded to Asp 235. Trp51, His52 and Arg48 are located in the N-terminal domain
above the heme and form the heme distal pocket. Due to these residues, the distal heme pocket
of CcP is quite polar. The heme active site structure of wild-type CcP is shown in Figure 1.6.

Figure 1.6: Active site structure of wild-type CcP.
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Cytochrome P450cam also has the heme group buried within the protein matrix. Unlike
CcP there is no obvious access channel for ligands to access the heme. The heme is coordinated
to Cys357 and the distal pocket contains Thr252, Leu244 and Val295. The heme active site
structure of P450cam is shown in Figure 1.7. The distal pocket in P450cam is relatively non-polar.

Figure 1.7: Active site structure of P450CAM.

1-Methoxynaphthalene

Shoji and coworkers have developed a simple colorimetric assay, based on the
hydroxylation of 1-methoxynaphthalene, to measure the peroxygenase activity of a number of
heme proteins [17]. The hydroxylation of 1-methoxynaphthalene is easily monitored by a color
change since the formation of 4-methoxy-1-naphthol is immediately followed by further

16

oxidation yielding Russig’s blue, Figure 1.8. The mechanism of Russig’s Blue formation starts
with the hydroxylation of 1-methoxynaphthalene. Then one-electron oxidation of 4-methoxy-1naphthol generates phenoxy radicals, which couple, forming Russig’s Blue.

Figure 1.8: Mechanism of Russig’s Blue formation.

The formation of Russig’s Blue reveals peroxygenase activity without the use of more
complex analytical techniques such as high performance liquid chromatography, gas
chromatography, and nuclear magnetic resonance measurements.

Research Objectives

Many of the substrates for the cytochrome P450 enzymes are very non-polar and have
limited solubility in water.

In fact, the purpose of many monooxygenase reactions is to

17

incorporate hydroxyl groups into non-polar substrates enhancing their water solubility and
allowing more efficient elimination of the substances from the body. The wide variety of
xenobiotics that serve as substrates for the cytochrome P450s make the P450s attractive catalysts
for specific chemical synthesis.

However, the complexity of the P450 reaction, with the

necessity of NAD(P)H and a reductase system in many cases, is not attractive for the synthesis
laboratory. If the peroxygenase activities of either the P450s or the peroxidases could be
enhanced this would make a major advance in using heme enzymes as practical laboratory
catalysts for oxygenation reactions.
Styrene epoxidation is often used in assessing both the monooxygenase and the
peroxygenase reactions in heme enzymes and we will use it in our study. However its poor
solubility in water limits the range of styrene concentrations that can be used.
Acrylonitrile is also used in epoxidation studies and has a much greater solubility in
water and will be used in our studies. Acrylonitrile also has an advantage in that it has been
previously shown that acrylonitrile can bind within the distal heme pocket of CcP [25].
The specific objectives of this work are to:
1. Investigate the peroxygenase activity of wild-type CcP using styrene and acrylonitrile as
substrates.
2.

Develop CcP mutants that have enhanced peroxygenase activity.

Since the wild-type

peroxygenase activity of CcP is so slow, the active site can be altered to increase partitioning of
styrene and acrylonitrile into the distal heme pocket at the expense of the very rapid reaction
between CcP and hydrogen peroxide. We will make the distal heme pocket more non-polar by
replacing Arg-48, Trp-51, and His-52, key residues that facilitate hydrogen peroxide activation,
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with either all alanine, all valine, or all leucine residues. These mutants with be called the
CcP(triAla), CcP(triVal), and CcP(triLeu) mutants respectively.
3.

Investigate the reactivity of CcP(H175C/D235L), a mutant developed by Yi Lu and

coworkers at the University of Illinois, Urbana-Champaign, which replaces the proximal
histidine residue with a cysteine residue and mimics the axial ligation of the P450s [16].
4. Investigate the steady-state hydroxylation of 1-methoxynaphthalene by CcP and the apolar
distal heme pocket mutants of CcP.
Investigations into the peroxygenase activity of CcP are important because they should
provide further insight into the structure/function relationships for both CcP and P450s. They
will also aid in understanding the mechanisms of these b-type heme enzymes. These studies may
also lead to improved heme enzymes with enhanced peroxygenase activities such that these
catalysts would prove useful in laboratory synthesis reactions.

Properties of the Oxygenation Substrates

Styrene is used as an industrial chemical used to produce reinforced plastics, polyester resins and
styrene butadiene rubber [26]. Styrene is non-polar and is quite reactive due to the ethene group.
It has limited water solubility and once absorbed into the body, P450 enzymes metabolize
styrene to styrene 7,8-oxide. Styrene 7,8 oxide has been classified as probably carcinogenic to
humans by the World Health Organization International Agency for Research on Cancer [27].
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Acrylonitrile is also used in industry for the production of plastics. It is used for the
industrial manufacturing of acrylamide and acrylic acid.

It is also classified as possibly

carcinogenic by the World Health Organization International Agency for Research on Cancer
[28]. The nitrile group makes acrylonitrile more water soluble than styrene and provides an
ethene group as an epoxidation site in the peroxygenase activity studies. The nitrile group is not
protonated and acrylonitrile exists only in the neutral unprotonated state in aqueous solution.

Both styrene and acrylonitrile have the possibility of binding within the distal heme
pocket of CcP due to their small size and, with their reactive ethene groups, should participate in
any potential peroxygenase activity that may be shown by CcP and its mutants.

CHAPTER TWO
MATERIALS AND METHODS

In this study, the peroxygenase activity of wild-type CcP was investigated using styrene,
acrylonitrile, and 1-methoxynapthalene as oxidizable substrates.

To further enhance the

peroxygenase activity, the active site of wild-type CcP was altered to provide a more non-polar
distal heme pocket in order to increase partitioning of apolar substrates into the distal heme
pocket, near the heme iron. In order to further understand the effect of axial ligation of CcP,
another CcP mutant, CcP(H175C/D235L), provided by Professor Yi Lu of the University of
Illinois, Urbana-Champaign, was investigated because of its similar active-site structure to that
of the cytochrome P450s.

Cloning, Expression, and Purification of rCcP and CcP Mutants

Research group members cloned mutants using the expression system for the
recombinant CcP (rCcP) developed by James Satterlee and colleagues, Washington State
University [29]. The CcP gene was modified to include an N-terminal methionine for bacterial
expression and the exact amino acid sequence of mature baker’s yeast CcP. The CcP gene is
inserted into the multiple cloning site of the Novagene vector pET24a(+) under control of the T7
promoter. The CcP mutants were created using the Stratagene QuikChange mutagenesis kit and
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sequenced in both directions to assure that, except for the intended mutations, the gene was
identical to the published sequence. The three CcP triple mutants constructed for this study are
CcP(triAla)

with

mutations

R48A/W51A/H52A,

CcP(triVal)

with

mutations

R48V/W51V/H52V, and CcP(triLeu) with mutations R48L/W51L/H52L.
Two mutants, CcP(H175C) and CcP(H175C/D235L), were kindly provided by Professor
Yi Lu of the University of Illinois, Urbana-Champaign.
Recombinant CcP and the CcP mutants were expressed in E. coli strain BL21(DE3) using
published procedures [30, 31]. The N-terminal methionine is removed from the rCcP produced
in this expression system. Cells were harvested by centrifugation and stored at -20⁰C. CcP and
its mutants were isolated by suspending the cells from 1 L of culture in approximately 15 mL
lysis buffer containing lysozyme, DNase, and RNase, incubated on ice for 15-20 minutes, then
passed through a French Press, at a pressure of approximately 15000 psi. Soluble proteins were
separated from the cell debris by centrifugation, dialyzed against 2 L 50 mM potassium
phosphate buffer, pH 6.0, and passed through a Sephadex G-75 column (2.5x90 cm). Fractions
containing apoCcP were pooled, the pH adjusted to 7.5 and about a 5 fold molar excess of hemin
added. After incubation in the dark for 1 to 2 hours, the pH was adjusted to pH 6.0, centrifuged
to remove insoluble material and applied to a diethylaminoethyl (DEAE)-Sepharose FastFlow
column (2.5x16 cm) equilibrated in 50 mM potassium phosphate buffer, pH 6.0. HoloCcP was
eluted using a linear gradient consisting of 200 mL 50 mM potassium phosphate and 200 mL of
1.0 M potassium phosphate, both at pH 6.0. Fractions were monitored by UV-vis spectroscopy
and fractions with absorbance ratios (408nm/280nm) >1 were pooled.

The sample was

concentrated on a small DEAE-Sepharose FastFlow column and dialyzed against several
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changes of deionized distilled water to induce crystallization. On occasion, CcP samples were
lyophilized after dialysis against deionized distilled water.

Other Materials

Styrene, acrylonitrile, 1-methoxynaphthalene, α-pinene, and commercial proteins were
purchased from Sigma/Aldrich.

Potassium phosphate, potassium acetate, pyridine, sodium

hydroxide, ethanol, hydrogen peroxide, and sodium hydrosulfite were purchased from Fisher
Scientific.

Buffers

Buffers were mixtures of KH2PO4 and K2HPO4 with a pH range between 5.5 and 8.0 and
a total ionic strength of 0.100 M.

Determination of Extinction Coefficients of rCcP and CcP Mutants

The extinction coefficients of rCcP and the CcP mutants were determined using the
pyridine hemochromogen method [32]. In this method, the heme group is extracted from CcP or
the CcP mutant by alkaline denaturation, bound to pyridine, and the heme iron reduced to
produce the pyridine/Fe(II) heme complex, the reduced pyridine hemochromogen.

The

extinction coefficients of the reduced pyridine hemochromogen are accurately known and the
concentration of the heme in the original CcP or CcP mutant solution can be determined.
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Aliquots of CcP or CcP mutant were added to 40% pyridine in 0.2 M sodium hydroxide
solution. Then small amounts of solid sodium hydrosulfite were repeatedly added, recording
spectra after each addition until a constant reduced spectrum was determined. The absorbance at
556 nm and 558 nm was recorded from each spectrum. A final spectrum of rCcP in 0.1 M ionic
strength potassium phosphate buffer was recorded along with the absorbance at 408 nm for rCcP
or 406 nm for each mutant. A Hewlett Packard Diode Array Spectrophotometer, Model 8452A,
was used to determine all spectra.
Using the extinction coefficient values reported by Berry and Trumpower in 1987 for the
pyridine hemochrome of 34.53 mM-1cm-1 at 556 and 31.27 mM-1cm-1 at 558 nm the average
heme concentration of each protein sample was calculated [32]. The absorbance in 0.1 M ionic
strength potassium phosphate buffer at the Soret maximum (408 nm for rCcP, 406 nm for
CcP(triAla), 408 nm for CcP(triVal) and 402 nm for CcP(triLeu)) was divided by the average
heme concentration to yield the extinction coefficient.

Rate of Compound I Formation of CcP Mutants

CcP Compound I formation is characterized by a red-shift in the Soret absorbance, from
408 nm in CcP to 420 nm in CcP Compound I, with the largest increase in absorbance occurring
at 424 nm [33]. The CcP triple mutants react slowly with hydrogen peroxide and manual mixing
techniques could be used to determine the rate of Compound I formation using the Hewlett
Packard Diode Array Spectrophotometer. Approximately 10 µM solutions of the CcP triple
mutants were made by adding small aliquots of stock solutions to 2 mL of a 0.1 M ionic strength
potassium phosphate buffer, pH 6.0, in a standard 10 mm pathlength cuvette. Initial spectra of
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the CcP samples were recorded and a small aliquot of hydrogen peroxide was added to initiate
the reaction. The solutions were mixed by repeated inversions of the cuvette and spectra
recorded immediately following mixing. Mixing was accomplished within 10 seconds and
spectra were recorded every 10 seconds for two hours. The reaction was studied as a function of
hydrogen peroxide concentration. The hydrogen peroxide was increased so that the final ratios
of enzyme to H2O2 were 1:3, 1:10, 1:30 and 1:100. The observed absorbance changes were
multiphasic since the rates of formation and decay of Compound I for the CcP triple mutants are
similar. The observed absorbance changes were fit to an equation representing a series of firstorder reactions (or pseudo first-order reactions) with each exponential term giving an observed
rate constant. The phase associated with an increase in absorbance at 424 nm was attributed to
Compound I formation and the phases associated with decreases in the absorbance at 424 nm
were attributed to the decay of Compound I. The observed rate constants were plotted as a
function of the hydrogen peroxide concentration and the slope of the plot gives the second-order
rate constant for Compound I formation.
The two mutants provided by Professor Yi Lu, University of Illinois, CcP(H175C) and
CcP(H175C/D235L) react rapidly with hydrogen peroxide and stopped flow techniques were
used to determine the rate of Compound I formation for these mutants.

On the Applied

Photophysics Stopped-Flow Spectrophotometer Model SX.17MV, an initial spectrum of 2.13
µM H175C/D235L CcP mutant in pH 6.0 0.1 M ionic strength potassium phosphate buffer was
obtained. Then excess hydrogen peroxide (6 µM to 105 µM) was added while recording spectra
at 390 nm. The observed reaction rates were plotted against the increasing hydrogen peroxide
concentration. The slope of the graph yields the bimolecular rate constant for the reaction. The
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reaction of the H175C/D235L CcP double mutant with hydrogen peroxide was determined at pH
4.5, 6.0, and 7.5.

Endogenous Reduction of CcP

CcP Compound I, formed by the stoichiometric addition of CcP and hydrogen peroxide,
is not stable but undergoes an endogenous reduction of the oxyferryl and tryptophan-191 radical
sites by oxidizable amino acid residues within the protein matrix. This endogenous reduction is
called the CcP Compound I decay reaction. The decay of Compound I of CcP and the CcP
mutants is slow and the reactions are typically observed for up to 24 hours.

Two

spectrophotometers were used to monitor the Compound I decay reactions, a Cary Model 219
Spectrophotometer and the Hewlett Packard Model 8452A Diode Array Spectrophotometer.
With the Cary 219 spectrophotometer, Compound I decay was observed at a single wavelength,
424 nm, while entire spectrum between 250 nm and 700 nm was acquired as a function of time
with the Hewlett Packard Model 8452A Diode Array Spectrophotometer.
In a typical experiment, an approximately 10 µM solution of CcP or of a CcP mutant was
placed in a standard 10 mm pathlength cuvette, the initial spectrum recorded, followed by the
addition of hydrogen peroxide with manually mixing, and the absorbance recorded as described
above.
The decay of Compound I was carried out after adding a stoichiometric amount of
hydrogen peroxide to CcP or the CcP mutants. The CcP Compound I decay reaction could also
be carried out in the presence of excess hydrogen peroxide. The heme group of CcP and the CcP
mutants is irreversibly oxidized in the presence of large excesses of hydrogen peroxide.
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Reduction of Compound I by Acrylonitrile and Styrene

Reduction of CcP Compound I by acrylonitrile or styrene is slow and competes with the
endogenous reduction (decay) of Compound I. This study is best described as monitoring the
endogenous reduction of CcP Compound I in the presence of increasing concentration of either
acrylonitrile or styrene.
Styrene is not very soluble in aqueous solution and stock solutions of styrene were made
up in ethanol. A maximum concentration of about 5.5 mM styrene in a 10% ethanol/buffer
solution could be used before phase separation was observed. An aliquot of an approximately
250 mM stock solution of styrene in ethanol was added to 2mL of 0.1 M potassium phosphate
buffer, pH 6.0, in a standard cuvette and the spectrum recorded on the Hewlett Packard Diode
Array Spectrophotometer Model 8452A. Then stoichiometric amounts of CcP and H2O2 were
added to generate CcP Compound I and spectra recorded every 5 minutes for 24 hours. Data
were analyzed by plotting the CcP Compound I reduction rate as a function of the styrene
concentration. The slope of this line yields the bimolecular rate constant for styrene reduction of
CcP Compound I.
Acrylonitrile is much more soluble in aqueous solution than styrene and the reduction of
CcP Compound I could be measured in the presence of up to 1.52 M acrylonitrile. The effect of
acrylonitrile on CcP Compound I reduction was investigated using both the Hewlett Packard
Diode Array Spectrophotometer Model 8452A and Cary Model 219 spectrophotometer.
Aliquots of acrylonitrile were added to a 0.10 M ionic strength potassium phosphate buffer, pH
6.0, and the spectrum recorded. Then stoichiometric equivalents of CcP and H2O2 were added,
manually mixed, and the absorbance change at 424nm was recorded over time for each
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concentration.

The data was analyzed by plotting the reaction rate as a function of the

acrylonitrile concentration, yielding the bimolecular rate constant for acrylonitrile reduction of
Compound I.

Steady State Activity of CcP(H175C/D235L)

CcP, found in baker’s yeast, protects the organism from the harmful effects of hydrogen
peroxide, by catalyzing the reduction of hydrogen peroxide to water using ferrocyctochrome c,
as shown in Equation 2.1, where C2+ represents ferrocyctochrome c and C3+ represents
ferricytochrome c.

2C2+ + H2O2 + 2H+ → 2C3+ + 2H2O
CcP

(2.1)

The steady state kinetics of CcP(H175C/D235L) catalyzed oxidation of ferrocytochrome
c by hydrogen peroxide was performed on a Hewlett Packard Diode Array Spectrophotometer,
Model 8452A, for comparison. Concentrations of 0.02 to 0.4 µM of H175C/D235L CcP were
added to 0.1 M potassium phosphate buffer, pH 7.5 containing 11.3 µM cytochrome c. Upon
addition of 200 µM hydrogen peroxide the absorbance was recorded over time at four
wavelengths; 314, 362, 448, and 548nm. The velocity for the reactions can be calculated from
the change in absorbance over time and the difference in extinction coefficients for ferro and
ferri cytochrome c. The velocities plotted over CcP(H175C/D235L) concentration yields the
enzyme turnover number.
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Russig’s Blue Formation

1-methoxynapthalene was used to perform a colorimetric assay to assess the
peroxygenase activity of rCcP and the CcP mutants.

When 1-methoxynapthalene is

hydroxylated, it eventually forms the product 4,4’-dimethoxy-[2,2’]-binaphthalenylidene-1-1’dione, called Russig’s blue, noted for its blue color. Russig’s blue formation allows us to see the
peroxygenation activity of CcP and its mutants without the use of high performance liquid
chromatography, gas chromatography, and nuclear magnetic resonance measurements [17].
The oxidation of 0.50 mM 1-methoxynapthalene in 0.1 M potassium phosphate buffer,
pH 7.0 was monitored by following formation of Russig’s Blue at 610nm on a Hewlett Packard
Diode Array Spectrophotometer Model 8452A. Changes in absorbance as a function of time
were converted to rates using an extinction coefficient of 1.4 x 104 M-1 cm-1 for Russig’s blue
formation at 610 nm in aqueous buffer solutions. The reaction was initiated by the addition of
1.0 mM hydrogen peroxide.

CHAPTER THREE
RESULTS

Peroxygenase Activity of Cytochrome c Peroxidase (CcP)

Endogenous Reduction of CcP Compound I

Ortiz de Montellano and coworkers have shown that CcP can catalyze the oxidization of
styrene, trans-β-methylstyrene, and cis-β-methylstyrene to their epoxides utilizing hydrogen
peroxide in a peroxygenase-type reaction [22]. However, the peroxygenase activity is very low,
with steady-state turnover rates on the order of 10-4 s-1 at pH 7. The peroxygenase activity is
about 7 orders of magnitude lower than the natural peroxidase activity of CcP, the oxidation of
ferrocytochrome c to ferricytochrome c by hydrogen peroxide.
One of the goals of this thesis is to determine if CcP Compound I can directly oxidize
substrates such as styrene and acrylonitrile to their epoxides. The work of Ortiz de Montellano
indicates that the peroxygenase reactions will be slow and it is anticipated that the endogenous
reduction of CcP Compound I may be a competing side reaction in these studies. Prior to
initiating the work with styrene and acrylonitrile, the endogenous reduction of CcP Compound I
was investigated at the experimental conditions that will be used to assess the peroxygenase
activity of CcP and CcP mutants.
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The reduction of CcP Compound I can be easily monitored by following the
spectroscopic changes in the enzyme as the oxyferryl, Fe(IV) center is reduced to the stable
Fe(III) redox state of the enzyme. Figure 3.1 shows the spectrum of CcP and CcP Compound I.
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Figure 3.1: Spectrum of CcP and CcP Compound I. (Upper Panel - Spectrum of CcP (thin line)
and CcP Compound I (thick line). Lower Panel - The difference spectrum of CcP Compound I
minus CcP).

The spectrum of the stable ferric state of CcP has a large Soret peak at 408 nm and the
delta (δ) band appearing as a distinct shoulder near 380 nm. CcP Compound I is generated by
the stoichiometric addition of hydrogen peroxide.

The spectrum of CcP Compound I is

characteristic of the Fe(IV) form of the enzyme with a Soret peak at 420 nm and alpha (α) and
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beta (β) bands at 560 nm and 530 nm, respectively. The δ band decreases in amplitude and shifts
to about 350 nm. The lower panel in Figure 3.1 shows the difference spectrum between CcP
Compound I and CcP. The largest difference between CcP Compound I and CcP occurs at 424
nm and isosbestic points are seen at 344, 412, and 454 nm in the Soret region.
The oxyferryl Fe(IV) and Trp-191 radical sites in CcP Compound I are not stable and, in
the absence of reducible substrates such as ferrocytochrome c, will be reduced to Fe(III) and
neutral tryptophan side chain by oxidizible amino acid residues within the protein itself in a
process called the endogenous decay or endogenous reduction of Compound I. Figure 3.2
shows the spectroscopic changes in CcP over a period of 24 hours after the stoichiometric
addition of H2O2 to CcP.
The spectrum of CcP Compound I, with Soret maximum at 420 nm, is generated within
the time it takes to mix the two reactants. Over the period of 24 hours, the Soret band decreases
in intensity and shifts to 408 nm as the Fe(IV) heme is reduced to the Fe(III) form of the enzyme.
The rate of the endogenous reduction of the Fe(IV) group can be determined by plotting the
change in absorbance at 424 nm as a function of time. The absorbance change at 424 nm in the
experiment shown in Figure 3.2 is plotted in Figure 3.3. The endogenous reduction of CcP
Compound I was also determined using a Cary Model 219 double-beam UV-vis recording
spectrophotometer. Data from the double-beam instrument were collected at 20 minute intervals
for 24 hours and are included in Figure 3.3.
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Figure 3.2: Endogenous reduction of CcP Compound I following a stoichiometric addition of
H2O2 to CcP. (A spectrum was acquired every 5 minutes for 24 hours, every tenth spectrum is
displayed).
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Figure 3.3: Endogenous reduction of CcP Compound I monitored with a Cary 219 double beam
instrument (solid circles) and HP diode array spectrophotometer (open circles). (The data have
been normalized by dividing by the initial absorbance in each of the data sets).
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There are slight differences in the two data sets. The absorbance changes at 424 nm
collected on the double beam instrument could be fit to a single exponential function with an
apparent first-order rate constant of (3.4  0.1) x 10-5 s-1. The diode-array data set is biphasic and
could be fit by a two-exponential equation with apparent first-order rate constants of (1.8 ± 0.1) x
10-3 s-1 and (3.0 ± 0.1) x 10-5 s-1. The faster reaction is a minor process accounting for about
13% of the absorbance change during the reaction. The rate constant for the major reaction
agrees with the rate constant determined from the data set acquired on the double beam
instrument. It is likely that in collecting data at 20 minute intervals with the double beam
instrument, the faster of the two endogenous reduction rates was missed due to an insufficient
number of data points. The half time of the fast reaction is about 9 minutes.
The biphasic decay process agrees with a 1975 study of Compound I decay using
authentic yeast CcP, which reported rate constants of (1.3 ± 0.3) x 10-3 s-1 and (2.9  0.6) x 10-5
s-1 [34]. In the 1975 study, the faster reaction was attributed to the reduction of the Trp-191
radical, which causes a small perturbation to the heme spectrum, while the slower reaction,
which has the largest change in absorbance at 424 nm, is ascribed to reduction of the Fe(IV)
heme to the Fe(III) state.

Reduction of CcP Compound I by Acrylonitrile

Ortiz de Montellano and colleagues showed that the heme pocket of CcP is accessible to
small substrates, such as phenylhydrazine, phenylthiomethyl ester, and styrene [22]. These
substrates can diffuse into the distal pocket and access the heme. Styrene can be oxidized via a
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peroxygenation reaction, i.e., by direct transfer of the oxyferryl oxo atom to the vinyl group of
styrene, producing styrene epoxide.

While Ortiz de Montellano showed that CcP has

peroxygenase activity, he also showed that CcP is not a very efficient catalyst for peroxygenation
reactions.
In this study, the rate of the peroxygenase reaction was measured by directly monitoring
the rate of CcP Compound I reduction by various substrates. The endogenous reduction rate of
CcP is a basis of comparison for slow reactions. The reduction of CcP Compound I, in the
presence of oxidizable substrates, should be faster than the endogenous reduction rate. In the
presence of oxidizable substrate, the observed reaction rate is equal to the rate of endogenous
reduction plus the rate of CcP Compound I reduction by the substrate. The mechanism for
reduction of CcP Compound I in the presence of an oxidizible substrate is given below. The first
reaction is the endogenous reduction of the Fe(IV) group with rate constant kd, Equation 3.1.

kd
CcP·I → CcP

(3.1)

The second reaction, Equation 3.2, includes rapid binding of the substrate, S, into the heme
pocket with an equilibrium dissociation constant, KD, followed by the slow transfer of the
oxygen atom from the oxyferryl, Fe(IV) heme to the substrate with rate constant k2.

KD
k2
CcP·I + S ⇄ CcP·I·S → SO + CcP

(3.2)
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The overall rate of Compound I reduction is given by Equation 3.3.

k obs  k d 

k 2 [S ]
K D  [S ]

(3.3)

Acrylonitrile, styrene and -pinene were selected as potential peroxygenase substrates
due to their small size and possible accessibility to the heme pocket. Both -pinene and styrene
are non-polar molecules with limited solubility in water. Even in the presence of solvents with
up to 10% acetone or ethanol, the low solubility prevented extensive studies of their oxidation by
CcP Compound I. Results with styrene will be presented in the next section but the -pinene
results were inconclusive and will not be reported in this thesis. The results with acrylonitrile,
which has a significantly higher solubility in aqueous buffer than styrene, will be presented first.
In the peroxygenase reaction, CcP Compound I will oxidize acrylonitrile to the epoxide
via direct oxygen transfer in a two-electron redox reaction, Equation 3.4.

CcP·I + acrylonitrile  CcP + epoxide

(3.4)

In these studies, the reactions were initiated by adding a stoichiometric amount of H2O2 to a
solution containing an equilibrium mixture of CcP and acrylonitrile. Compound I is formed
within the mixing time of the reactants and the reduction of Compound I was followed at 424
nm. A series of experiments with increasing concentrations of acrylonitrile were performed with
concentrations of acrylonitrile as high as 1.52 M, a concentration approaching the solubility limit
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of acrylonitrile. Figure 3.4 shows the time rate of change of the absorbance at 424 nm at five
different concentration of acrylonitrile between 0 and 0.608 M. Three series of experiments
were performed, one carried out with the Cary Model 219 spectrophotometer and two carried out
with the HP diode-array spectrophotometer. Above 0.10 M acrylonitrile, the data fit a single
exponential expression as a function of time from which the observed rate constant could be
determined. Table 3.1 lists the observed rate constants for the reduction of CcP Compound I
between 0 and 1.52 M acrylonitrile.
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Figure 3.4: Effect of acrylonitrile on the reduction of CcP Compound I. (The acrylonitrile
concentrations, [ACN], are indicated adjacent to each plot).
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Table 3.1. Rate of Reduction of CcP Compound I by Acrylonitrile.a
kobs (s-1)
[Acrylonitrile] (M)

A – Cary 219

B – HP 84652A

C – HP 8452A

(1.8 ± 0.1) x 10-3

(1.4 ± 0.1) x 10-3

(1.9 ± 0.1) x 10-3

(1.5 ± 0.1) x 10-3

(2.7 ± 0.1) x 10-3

(3.1 ± 0.1) x 10-3

0.610

(3.9 ± 0.1) x 10-3

(5.0 ± 0.1) x 10-3

0.910

(5.7 ± 0.1) x 10-3

(5.8 ± 0.1) x 10-3

1.22

(6.0 ± 0.1) x 10-3

(7.6 ± 0.4) x 10-3

1.52

(6.6 ± 0.1) x 10-3

(8.8 ± 0.1) x 10-3

0.000
0.061
0.122

(2.4 ± 0.4) x 10-3
(1.6 ± 0.1) x 10-3

0.152
0.243

(1.9 ± 0.1) x 10-3

0.300
0.304

(2.7 ± 0.1) x 10-3

0.365
0.486

(3.4 ± 0.1) x 10-3
(4.3 ± 0.1) x 10-3

0.608

(5.2 ± 0.2) x 10-3

a

pH 6.0, 0.100 M I, 25 °C.

The observed rates of these reactions are plotted versus acrylonitrile concentration in
Figure 3.5.
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Figure 3.5: Observed rate of reduction of CcP Compound I. (Cary 219 data (open circles), HP
diode array run 1 (solid circles), and HP diode array run 3 (solid triangles). The solid and dashed
lines are discussed in the text).

There is good agreement between the three experiments. Within the experimental error,
the observed first-order rate constants increase linearly with acrylonitrile concentration as is to
be expected for a bimolecular reaction between two reactants. The dashed line in Figure 3.5 is
the linear least squares fit to the data. The intercept is (1.6 ± 0.2) x 10 -3 s-1, within experimental
error of the initial rate of endogenous reduction of CcP Compound I, and the slope gives a
bimolecular rate constant of (4.3  0.3) x 10-3 M-1 s-1 for the oxidation of acrylonitrile.
In a companion study, Diana Chinchilla investigated the binding of acrylonitrile to the
heme in CcP between pH 4 and 8 [25]. She found that the equilibrium dissociation constant for
the CcP-acrylonitrile complex was 1.2 ± 0.3 M, independent of pH. With knowledge of the
binding of acrylonitrile to CcP, we can also use Equation 3.3 to fit the observed rate of CcP
Compound I reduction in the presence of acrylonitrile. Fixing the value of KD at 1.2 M in
Equation 3.3, non-linear least squares regression (solid line) gives best-fit values of kd and k2 of
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(1.4  0.5) x 10-3 s-1 and (1.02  0.16) x 10-2 s-1, respectively. The maximum turnover rate, k2, is
equivalent to 0.61 min-1, a rate that is comparable to the acrylonitrile epoxidation activity of liver
microsomal cytochrome P450s.
Liver microsomal preparations catalyze the epoxidation of acrylonitrile as a major
pathway for the elimination of acrylonitrile in the body [35]. Rat liver microsomal P450’s
maximum turnover rates range between 0.26 and 4.9 min-1 based on the total cytochrome P450
content of the microsomal preparations [35–39].

Reported human liver microsomal P450

preparations epoxidize acrylonitrile with maximum turnover rates between approximately 1.3 x
10-4 to 1.7 min-1 [36, 38, 40].

Styrene Solubility

Styrene is not very soluble in water, its’ reported solubility is 2.98 mM at 25 C [41]. The
spectrum of 1.75 mM styrene in a pH 6.0, 0.100 M ionic strength potassium buffer is shown in
Figure 3.6. In an effort to attain higher concentrations of styrene in aqueous solution, aliquots of
a stock solution of styrene in ethanol were added to the pH 6.0 buffer and the absorption
spectrum determined after equilibration of the samples. A plot of the absorbance at 289 nm as a
function of the styrene concentration is shown in Figure 3.7.

Solutions with styrene

concentrations in excess of 7 mM could be obtained. The final solutions were homogeneous and
contained less than 3% ethanol.

The slope of the absorbance as a function of styrene

concentration yields an extinction coefficient of 0.223  0.009 mM-1 cm-1 at 289 nm.
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Figure 3.6: Spectrum of 1.75 mM styrene in aqueous buffer.
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Figure 3.7: Absorbance at 289 nm versus the styrene concentration.
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Reduction of CcP Compound I by Styrene

After determining the solubility of styrene, the rate of reduction of CcP Compound I was
determined using the maximum possible styrene concentrations. CcP Compound I was preformed by the addition of stoichiometric amounts of CcP and H2O2. Then a small aliquot of a
stock solution of styrene in ethanol was added to the Compound I and the reaction followed at
424 nm.

The reduction of CcP Compound I does not change much over the accessible

concentration range of styrene. The time rate of change of the absorbance at 424 nm in the
presence of styrene is very similar to the endogenous reduction of Compound I. Plots of the
absorbance as a function of time were biphasic and fit to a two exponential equation. The
observed rate constants are very similar to those determined for the endogenous reduction of
Compound I. The observed rate for the reduction of the Fe(IV) site as a function of the styrene
concentration is shown in Figure 3.8. A linear least squares analysis of the data yields a slope of
(4.6  4.1) x 10-4 M-1 s-1 and an intercept of (2.9  0.1) x 10-5 s-1. The intercept is within
experimental error of the endogenous reduction rate for the Fe(IV) site and the slope is a factor
of ten smaller than the initial rate of CcP Compound I reduction by acrylonitrile, Figure 3.5.
Styrene reduces CcP Compound I at a slower rate than acrylonitrile.
In the accessible range of aqueous styrene concentrations, styrene has very little effect on
the rate of reduction of CcP Compound I. The bimolecular rate constant for the oxidation of
styrene by CcP Compound I, (4.6  4.1) x 10-4 M-1 s-1, gives an apparent turnover number of (1.4
± 1.2) x 10-4 min-1 using 5 mM styrene. This is about two-orders of magnitude slower than the
steady-state activities reported by Ortiz de Montellano [23]. This could mean that the steady-
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state oxidation of styrene observed by Ortiz de Montellano may go through a different
mechanism, perhaps by the co-oxidation mechanism his group first proposed for myoglobin, in
which H2O2 generates a protein based radical and that radical migrates to the surface of the
proteins, interacting with molecular oxygen, and incorporating one of the O2 atoms into the
organic substrate [42].
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Figure 3.8: The rate of CcP Compound I reduction in the presence of styrene.

Properties of CcP(triAla), CcP(triVal), and CcP(triLeu)

Ortiz de Montellano and colleagues were the first to show that wild-type CcP can
catalyze peroxygenase reactions with their study of the epoxidation of styrene, trans-βmethylstyrene, and cis-β-methylstyrene [22]. The styrene epoxidation reaction is quite slow and

43

over the range of styrene concentrations accessible in aqueous solution it was difficult to show
that CcP Compound I could directly oxidize styrene. The problem appears to be that the binding
of styrene within the heme pocket of CcP is very weak and that binding and oxidation of styrene
has a rate similar to that of the endogenous reduction of CcP Compound I. Using a substrate that
has a much higher solubility in water than styrene, we were able to show direct oxidation of
acrylonitrile by CcP Compound I, comparable to published acrylonitrile epoxidation activity of
liver microsomal P450s [35-40]. However, even with acrylonitrile, CcP is not a very efficient
peroxygenase since the binding of acrylonitrile in the heme pocket of CcP is very weak, with an
equilibrium dissociation constant of 1.2 ± 0.3 M [25, 43].

In an effort to increase the

peroxygenase activity of CcP, we decided to make the heme pocket more apolar in order to
increase the binding affinity for small nonpolar compounds that are the typical substrates for the
monooxygenases such as cytochrome P450 and the peroxygenases.
The distal heme pocket of CcP is quite polar being defined by three residues: arginine 48
(Arg48), tryptophan 51 (Trp51) and histidine 52 (His52) as seen in Figure 1.6. His52 is
essential for the peroxidase activity of CcP, accelerating the rate of reaction with H2O2 by over
six orders of magnitude compared to the reaction between free heme and H2O2 [44]. In order to
make the distal heme pocket more apolar, Arg48, Trp51, and His52 were simultaneously mutated
to all alanines, all valines, or all leucines. These three CcP mutants are designated CcP(triAla),
CcP(triVal) and CcP(triLeu), respectively. These variants create a more hydrophobic distal
heme pocket in which small nonpolar substrates should be able to bind with greater affinity than
in the polar heme pocket of wild-type CcP. It was anticipated that elimination of His52 would
drastically decrease the rate of reaction between CcP and H2O2 but it was thought that the rate of
reaction with H2O2 could be sacrificed in order to increase the binding affinity of the apolar
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substrates. The studies described below are the initial characterization of these three apolar
distal heme pocket mutants of CcP.

Spectroscopic Properties

All heme proteins have four absorption bands in the UV-visible region of the spectra: α,
β, γ, δ. The γ band is also referred to as the Soret band. The positions of the four bands and the
extinction coefficients are dependent on the spin and coordination state of the heme group. The
ferric heme group can exist in three states: penta-coordinate high-spin, hexa-coordinate highspin and hexa-coordinate low-spin. The Soret band occurs, near 400 nm at its maximum, in the
blue region of the spectrum. It is the largest band in the absorption spectrum of all heme
proteins. The extinction coefficient at the Soret maximum is on the order of 100 mM-1 cm-1.
The α and β bands occur in the visible region of the spectrum. The α band occurs between about
550 and 590 nm and the β band between about 520 and 550 nm. The extinction coefficients of
these bands are about ten times smaller than that of the Soret band. The δ band occurs between
about 350 and 390 nm. Its extinction coefficient is dependent on heme coordination. In addition
to the other bands, high-spin ferric heme proteins have two ligand-to-metal charge transfer bands
designated CT1 and CT2. CT1 occurs between about 600 and 650 nm and CT2 occurs near 500
nm.

The charge transfer bands dominate the visible region of the spectrum for high-spin

complexes. Usually, the α and β bands appear as small inflections on CT2 in high-spin ferric
heme spectra. Both the position of the bands and the extinction coefficient provide important
information about the nature of heme ligation.
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In general, CcP and its mutants are stable between pH 4 and 8. In collaboration with Anil
Bidwai and other members of the laboratory we determined the pH dependence and the
extinction coefficients of the electronic absorption spectra of the three triple mutants.
Absorbance spectra of CcP(triAla), CcP(triVal) and CcP(triLeu) at pH 4, 6, and 8 are shown in
Figures 3.9, 3.10 and 3.11, respectively, where the visible region of each spectrum is expanded
by a factor of 5 [45]. As seen in the figures, the absorption spectra of the three mutants are
dependent upon pH.
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Figure 3.9: Spectra of CcP(triAla). pH 4.0 (dashed line), pH 6.0 (thick solid line), and pH 8.0
(thin solid line)). (The visible region of the spectrum shown is expanded by a factor of 5).
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Figure 3.10: Spectra of CcP(triVal). pH 4.0 (dashed line), pH 6.0 (thick solid line), and pH 8.0
(thin solid line)). (The visible region of the spectrum shown is expanded by a factor of 5).
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Figure 3.11: Spectra of CcP(triLeu). pH 4.0 (dashed line), pH 6.0 (thick solid line), and pH 8.0
(thin solid line)). (The visible region of the spectrum shown is expanded by a factor of 5).
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The extinction coefficients of all three mutants were determined experimentally at pH
6.0, using the pyridine hemochromogen method [32]. Selected spectroscopic parameters for the
three mutants as well as that for the recombinant form of wild-type CcP are included in Table
3.2.

Table 3.2. Spectroscopic parameters for rCcP and CcP Mutants at
pH 6.0.
δ
λ (ε) b

Soret
λ (ε) b

CT2a
λ (ε) b

β
λ (ε) b

α
λ (ε) b

CT1 a
λ (ε) b

rCcP

374
(60)*

408
(101)

504
(11.2)

542
(9.2)*

590
(3.7)*

641
(3.5)

CcP(triAla)

371
(82)*

405
(92)

497
(9.6)*

536
(9.0)*

580
(5.7)*

632
(3.7)*

CcP(triVal)

378
(75)*

406
(93)

515
(11.2)

550
(7.2)*

590
(4.4)*

640
(3.3)

CcP(triLeu)

380
(98)*

401
(117)

505
(16.2)

535
(13)*

580
(6.8)*

673
(5.8)

CcP(H175C
/D235L)

388
(72)*

406
(79)

508
(11.5)

540
(6.3)*

590
(6.3)*

632
(6.6)

Protein

a

CT1 and CT2 represent charge transfer bands. b λ, wavelength in nm.
ε, extinction coefficient in mM-1 cm-1; * follows the value of ε if the
band is a shoulder.

The Soret bands of the three mutants are all at shorter wavelengths than the Soret band of
recombinant CcP, which occurs at 408 nm. The Soret bands occur at 405, 406, and 401 nm for
CcP(triAla), CcP(triVal), and CcP(triLeu), respectively. At pH 4, the Soret bands are blueshifted compared to the positions at pH 6, occurring at 403 nm for CcP(triAla), 391 nm for
CcP(triVal) and 396 nm for CcP(triLeu). The maximum absorptivity in the Soret band decreases
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at pH 4 in comparison to the maximum absorptivity at pH 6. This is attributed to the onset of
acid denaturation. There is a red shift of the Soret band as the pH is raised above pH 6. The
Soret peaks occur at 410 nm for CcP(triAla), 408 nm for CcP(triVal) and 409 nm for CcP(triLeu)
at pH 8.
The pH dependence of the spectra for the triple mutants is shown in Figure 3.12. The
wavelength monitored for each of the mutants is the position of the Soret maximum at pH 4.
The extinction coefficients at these wavelengths are plotted as a function of pH in Figure 3.12.
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Figure 3.12: pH dependence of the triple mutant spectra. (The wavelength of the plots
correspond to the Soret maxima at pH 4 for each of the mutants: 403 nm for CcP(triAla), 391
nm for CcP(triVal), and 396 nm for CcP(triLeu)).

All three mutants have a bell-shaped dependence on pH revealing that the spectra are
influenced by a minimum of two acid/base transitions within the proteins. Only estimates of the
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apparent pKa values for the more acidic transition could be made since the low pH limit could not
be measured. Assuming that the spectrum in the acid denatured form of the mutants is that of
aqueous heme, the estimated pKa values for the acid transition are ~3.7, ~3.5, and ~3.5 for
CcP(triAla), CcP(triVal), and CcP(triLeu), respectively [46]. The apparent pKa values for the
more alkaline transition are 6.2 ± 0.2, 6.2 ± 0.3, and 7.1 ± 0.2 for CcP(triAla), CcP(triVal), and
CcP(triLeu), respectively.
The spectra indicate that the mutants consist of mixtures of penta and hexa coordinate
forms with both high and low spin forms existing at pH 6. When the pH is lowered to 4, the
mutants are almost exclusively in a high spin form, either penta-coordinate or with a water bound
to the heme iron. The more acidic transition, with pKa values near 3.5 is attributed to the onset
of acid denaturation. At pH 8, the spectra of all three mutants have the characteristic of a hexacoordinate low-spin heme. The most likely ligand at alkaline pH is the hydroxide ion, and the
apparent pKa values between 6.2 and 7.1 represent the ionization of a heme bound water
molecule.

Steady-State Activity

The natural activity of CcP is to catalyze the oxidation of ferrocytochrome c utilizing
hydrogen peroxide, Equation 3.5.

2 C2+ + H2O2 + 2 H+ → 2 C3+ + 2 H2O
CcP

(3.5)
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It was anticipated that the CcP triple mutants would have very low peroxidase activity
due to replacement of the distal histidine residue with apolar residues. In collaboration with
other members of the laboratory (D. Wroblewski and J. Erman), the catalytic activity of the CcP
triple mutants was determined at pH 6.0, Figure 3.13.
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Figure 3.13: Steady-state catalytic activity of CcP triple mutants. (Initial velocities, v0, are
plotted as a function of the enzyme concentration, e0).

The mutants all have detectable catalytic activity but the activity is diminished by 4 to 5
orders of magnitude compared to wild-type CcP, Table 3.3. CcP(triAla) is the most active of the
triple mutants having a 16-fold higher activity than CcP(triVal) and CcP(triLeu), which have
essentially the same activity.
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Table 3.3. Steady-state activity of the CcP triple mutants and k1
determination.a
v0/e0 (s-1)
k1 (M-1 s-1)
CcP(triAla)
(9.1 ± 0.3) x 10-2
91 ± 3
-3
CcP(triVal)
(5.8 ± 0.3) x 10
5.8 ± 0.3
-3
CcP(triLeu)
(5.7 ± 0.2) x 10
5.7 ± 0.2
b
yCcP
1900
(4.5 ± 0.3) x 107 e
680 c
rCcP
> 640 d
(4.8 ± 0.2) x 107 d
a
Experimental conditions: [ferrocytochrome c] = 9.0 µM, [H2O2] = 1.0 mM,
pH 6.0, 0.10 M ionic strength potassium phosphate buffer, 25 ºC. b pH 6.0,
0.20 M ionic strength [21]. c pH 7.5 [47]. d pH 7.5 [48]. e[49].

As will be seen in the next section, it is difficult to determine the rate constant for
Compound I formation by the triple mutants, k1, by directly measuring the change in absorbance
as a function of time after adding hydrogen peroxide. However, the rate of Compound I
formation can be determined from steady-state activity measurements. The value of k1, in terms
of the steady-state velocity, is given by Equation 3.6 when the reaction between H2O2 and
enzyme is rate limiting.

v0
e0
k1 
[ H 2 O2 ]

(3.6)

The values of the rate of reaction between H2O2 and the triple mutants, determined from
the steady-state measurements, are included in Table 3.3 and compared with the rate constant for
wild-type yeast CcP (yCcP) and recombinant CcP (rCcP) determined by measuring the rate of
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Compound I formation. The value of k1 varies from 5.7 ± 0.2 M-1s-1 for CcP(triLeu) to 91 ± 3 M1 -1

s for CcP(triAla), some 6 to 7 orders or magnitude smaller than for wild-type rCcP.

Reaction with H2O2

As discussed above, when hydrogen peroxide is added to CcP, CcP Compound I is
formed. This reaction is very rapid and is one of the distinguishing features of the peroxidases.
In the absence of reducible substrates CcP Compound I undergoes endogenous reduction. It is
the formation of CcP Compound I and the subsequent reduction of CcP Compound I by
acrylonitrile and styrene that allowed us to determine the peroxygenase activity of wild-type
CcP. If we are going to use this same technique to measure the peroxygenase activity of the CcP
triple mutants it is important that the mutants form a stable Compound I type intermediate.
To determine the rate of formation of Compound I and its subsequent decay for the triple
mutants, aliquots of hydrogen peroxide were added to the enzyme and the reaction followed
spectrophotometrically using a diode array spectrophotometer. The reaction between 100 µM
H2O2 and 9.9 µM CcP(triAla) at pH 6.0 is shown in Figure 3.14. It was followed for two hours.
A plot of the absorbance at 424 nm, the wavelength characteristic of Compound I formation, as a
function of time is shown in Figure 3.15.
CcP(triAla) does not appear to form a CcP Compound I-type intermediate upon the
addition of hydrogen peroxide since there was no significant increase in the absorbance at 424
nm. Rather there was an immediate decrease in absorbance in the Soret region, Figure 3.14,
suggesting that the heme undergoes irreversible oxidative degradation.

The decrease in

absorbance at 424 nm as a function of time is biphasic and can be fit to a two exponential
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function.

The best-fit values for the observed rated constants, designated kd1 and kd2, are

independent of the H2O2 concentration between 3 µM and 1.0 mM. The two observed first-order
rate constants are designated kd1 and kd2 with the subscript “d” indicating heme degradation. The
average values of kd1 and kd2 for the CcP(triAla) – H2O2 reaction are (2.9 ± 0.8) x 10-3 s-1 and
(3.8 ± 0.8) x 10-4 s-1, respectively. Average values of kd1 and kd2 are collected in Table 3.4. for
CcP(triAla) as well as for the other two triple mutants. Also included in Table 3.4 are the rates
of endogenous reduction of rCcP and yeast CcP (yCcP) for comparison. It must be pointed out
that the heme degradation rates for the triple mutants and the endogenous Compound I reduction
rates for rCcP and yCcP are for different processes although the rates are similar.
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Figure 3.14: Reaction of CcP(triAla) and H2O2 at pH 6.0. (The dashed line shows the spectrum
of 9.9 µM CcP(triAla) in the absence of H2O2. After addition of H2O2 (final concentration 100
µM), spectra are shown at 1 min intervals for the first 20 min, 2 min intervals between 20 and 60
min and 5 min intervals between 60 and 120 minutes for the reaction).
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Figure 3.15: Kinetic plots for the reaction between H2O2 and the CcP triple mutants.
(Experimental conditions: [CcP(triAla)] = 9.9 µM, [H2O2] = 100 µM; [CcP(triVal)] = 9.3 µM,
[H2O2] = 94 µM; [CcP(triLeu)] = 7.5 µM, [H2O2] = 75 µM).

Table 3.4. Rate of Compound I Formation and Decay for rCcP and CcP Mutants
at pH 6.0.
k1 a
(M-1 s-1)

Protein

transient-state

kd1 b
(s-1)

kd2 b
(s-1)

steady-state

yCcPc

(4.5 ± 0.3) x 107

(1.3 ± 0.3) x 10-3

(2.9 ± 0.6) x 10-5

rCcP

(4.8 ± 0.2) x 107

(1.8 ± 0.1) x 10-3

(3.2 ± 0.2) x 10-5

CcP(triAla)

ND d

91 ± 3

(2.9 ± 0.8) x 10-3

(3.8 ± 0.8) x 10-4

CcP(triVal)

20 ± 4

5.8 ± 0.3

(2.5 ± 2.4) x 10-3

(2.3 ± 0.9) x 10-4

CcP(triLeu)

170 ± 10

5.7 ± 0.2

(2.1 ± 1.0) x 10-3

(3.8 ± 1.7) x 10-4

CcP(H175C
/D235L)

(1.2 ± 0.1) x 106

(5.3 ± 0.4) x 10-3

(8.8 ± 0.6) x 10-5

a

Rate of CcP-I formation. b Rate of Compound I decay.
c
Data from references [34, 49]. d Reaction not detected.
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In contrast to CcP(triAla), CcP(triVal) shows an initial increase in absorbance at 424 nm
when hydrogen peroxide is added, Figure 3.15. This initial increase can be taken as evidence
for the formation of a Compound I-like intermediate. The rate of the initial absorbance increase
at 424 nm increases with increasing hydrogen peroxide concentration for the CcP(triVal)
reaction, Figure 3.16.
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Figure 3.16: Hydrogen peroxide dependence of k1obs for CcP(triVal). (The dashed line is the
linear least-squares fit to the data, while the solid line is a hyperbolic fit to the data).

A weighted linear-least squares fit to the observed rate constant gives a best-fit value for
the slope (k1) of 10 ± 2 M-1s-1, Table 3.4, which is about 70% higher than the value of k1
estimated from the steady-state kinetics of the CcP(triVal) catalyzed oxidation of
ferrocytochrome c, Table 3.3. The data shown in Figure 3.16 could also be fit to a hyperbolic
function of the hydrogen peroxide concentration, from which an apparent value for k1 can be
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found from the initial slope. The apparent value for k1 from the hyperbolic fit is 20 ± 4 M-1s-1,
about 4 times faster than the steady-state value. It should be noted that Anil Bidwai, et. al.
observed a hyperbolic dependence of both cyanide binding and imidazole binding to the heme in
CcP(triVal) suggesting that conformational changes in the protein limits binding of small ligands
to the heme [45, 46]. The hyperbolic dependence of k1obs on the hydrogen peroxide is considered
the best interpretation of the current data for the initial reaction between CcP(triVal) and
hydrogen peroxide. The value of k1 for the CcP(triVal)/H2O2 reaction included in Table 3.4 is 20
± 4 M-1s-1.
During the reaction between CcP(triLeu) and hydrogen peroxide shown in Figure 3.15
there is a small initial increase in the absorbance at 424 nm. In contrast to the CcP(triVal)
hydrogen peroxide reaction, this increase was only observed when the ratio of H2O2 to
CcP(triLeu) was about 10. The increase was not observed when the ratio of H2O2 to CcP(triLeu)
was 3, 30, or 100.

Using this singular value of k1obs at 75 µM H2O2 gives an apparent

bimolecular rate constant of 170 ± 10 M-1s-1, Table 3.4. The value of k1 determined from the
absorbance increase at 424 nm for the CcP(triLeu) reaction is about 30-fold higher than the value
of k1 from the steady-state data. The very small amplitude for the increase in absorbance at 424
nm, Figure 3.15, along with the fact that the increase was only observed when the ratio of H2O2
to CcP(triLeu) was ~10, and that the value of k1 calculated from the absorbance increase is 30fold higher than the steady-state value causes some doubt in the suggestion that the absorbance
increase is associated with Compound I formation for this mutant. However, the absorbance
measurements for Compound I formation could be influenced by the much larger amplitude
reactions associated with the heme degradation observed with the CcP triple mutants.
Irrespective of whether the steady-state values or transient-state values are used, the k1 values for
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both CcP(triVal) and CcP(triLeu) are five to six orders of magnitude smaller than that of rCcP,
(4.8 ± 0.2) x 107 M-1s-1.

This observation is consistent with previous studies in which

replacement of the distal histidine, His52, with apolar residues causes a five- to six-order of
magnitude decrease in the rate of reaction with H2O2 [44]. His52 functions as a base catalyst,
facilitating the ionization of hydrogen peroxide within the distal heme allowing the peroxide
anion to bind to the heme iron during formation of Compound I.

Heme Degradation

The reactions of wild-type CcP with hydrogen peroxide, Figures 3.2 and 3.3 are
fundamentally different than the reactions of the triple mutants, as exemplified by the
CcP(triAla) reactions, Figures 3.14 and 3.15. In the absence of a reducible substrate such as
ferrocytochrome c, addition of hydrogen peroxide to CcP forms CcP Compound I within the
time it takes to manually mix the two reactants. Subsequently, CcP Compound I will undergo an
endogenous reduction of the Trp-191 radical and the Fe(IV) sites with rate constants of (1.8 ±
0.1) x 10-3 s-1 and (3.2 ± 0.6) x 10-5 s-1.
With the triple mutants, the reaction with hydrogen peroxide to form Compound I and the
rate of heme degradation are apparently of the same magnitude and the amount of Compound I
does not build up to a significant concentration. The small excess of hydrogen peroxide needed
to increase the rate of Compound I formation also leads to significant heme degradation in the
absence of an oxidizible substrate. The reactions of CcP(triAla), CcP(triVal) and CcP(triLeu)
with 10 equivalents of H2O2 was observed by monitoring the change in absorbance in the Soret
region over time, Figures 3.14 and 3.15. The absorbance change at 424 nm as a function of
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time for each triple mutant can be fit to a two-exponential equation. The heme degradation rates
for CcP(triAla) are (2.9 ± 0.8) x 10-3 s-1 and (3.8 ± 0.8) x 10-4 s-1, for CcP(triVal) are (2.5 ± 2.4) x
10-3 s-1 and (2.3 ± 0.9) x 10-4 s-1 and for CcP(triLeu) are (2.1 ± 1.0) x 10-3 s-1 and (3.8 ± 1.7) x
10-4 s-1, Table 3.4.
These rates are similar to those of native CcP Compound I endogenous reduction.
However, to repeat, the reactions are fundamentally different. The reaction between H2O2 and
the triple mutants is so complex and the rate of formation of the Compound I intermediate is so
slow, that we are unable to determine the peroxygenase activity of the triple mutants by direct
observation of reduction of Compound I as we did for wild-type CcP.

Properties of CcP(H175C/D235L)

Professor Yi Lu and colleagues of the University of Illinois Urbana Champaign have
been using CcP as a heme protein scaffold to engineer new metal binding sites and to mimic
other heme protein activities. They added copper binding sites in CcP to mimic cytochrome c
oxidase [50] and have mutated the proximal histidine in CcP, His175, to a cysteine residue and
aspartate 235, Asp235, to a leucine residue in order to mimic cytochrome P450 heme
coordination [16]. Professor Lu has been primarily interested in the structural and spectroscopic
properties of his mutant enzymes and provided us with a sample of CcP(H175C/D235L) in order
to test its catalytic activity and reaction with hydrogen peroxide. Since this is a cytochrome
P450 mimic and cytochrome P450s catalyze oxygenase activities we also wanted to test the
peroxygenase activity of this mutant.
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The active site structures of CcP and P450 are illustrated in Figures 1.6 and 1.7 of
Chapter 1. In P450, the proximal cysteine ligand is in a hydrophobic environment provided by a
phenylalanine residue. The strong electron donation from the thiolate of the cysteine residue to
the iron is proposed to be responsible for the heterolytic cleavage of the oxygen-oxygen bond in
the Fe(II)O2 intermediate, which results in Compound I formation [51]. (See Chapter 1 for
information on the P450 catalytic cycle). CcP has a proximal histidine residue with a negatively
charged aspartate residue that normally forms hydrogen bonds to the histidine ligand. Replacing
the histidine 175 residue only with a cysteine does not result in thiolate ligation [52]. In 1999,
Lu and colleagues engineered a CcP double mutant in order study the stabilizing factors of
heme-thiolate ligation [16]. By replacing the histidine 175 with a cysteine and the aspartate 235
with the non-polar amino acid leucine (H175C/D235L), Lu and colleagues found that hemethiolate ligation was more stable. This double mutant may improve the peroxygenase activity of
CcP by creating a more P450 type active site.

Spectroscopic Properties

The absorption spectrum of CcP(H175C/D235L) is shown in Figure 3.17, where the
visible region of the spectrum is expanded by a factor of 5. The double mutant has a Soret band
maximum about 406 nm and CT2, β, and CT1 bands at 508, 540, and 632 nm, respectively,
Table 3.2. The spectrum indicates that the heme in this mutant is a high-spin penta-coordinate
form at pH 6. The spectral properties of the CcP mutant are similar to those of cytochrome P450
[16].
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Figure 3.17: Spectrum of CcP(H175C/D235L) at pH 6.0. (The visible region of the spectrum is
expanded by a factor of 5).

Steady-State Activity

The catalytic activity of CcP(H175C/D235L) was tested at pH 7.5 in 0.10 ionic strength
potassium phosphate buffer with 11.3 µM ferrocytochrome c(C102T) and 200 µM hydrogen
peroxide. Ferrocytochrome c oxidation was measured at 550 nm. A plot of the initial velocity,
corrected for the blank rate, as a function of the mutant enzyme concentration is shown in Figure
3.18. The slope of the plot gives a turnover number of 0.24 ± 0.01 s-1.
The turnover number of wild-type CcP is 510 ± 50 s-1, under comparable conditions. The
double mutation decreases the catalytic activity of CcP by a factor of 2,100. However, the
activity of the CcP(H175C/D235L) mutation is 3 to 40 times higher than CcP(triAla),
CcP(triVal), and CcP(triLeu), Table 3.3.
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Figure 3.18: Catalytic activity CcP(H175C/D235L). (Plot of the initial velocity, v0, for the
steady state oxidation of ferrocyctochrome c by H2O2 as a function of enzyme concentration).

Reaction with H2O2

The reaction of CcP(H175C/D235L) with hydrogen peroxide was investigated with both
stopped-flow and manual mixing techniques.

Figure 3.19 shows the spectrum of 12 µM

CcP(H175C/D235L), the spectrum of the intermediate formed within 10 seconds of manually
mixing the mutant with a stoichiometric amount of hydrogen peroxide, and the spectrum of the
stoichiometric mixture of mutant and hydrogen peroxide after 24 hours.
As will be seen below, CcP(H175C/D235L) reacts with hydrogen peroxide within the
time it takes to manually mix the reactants. The spectrum shown in Figure 3.19 obtained within
10 seconds on mixing the mutant and hydrogen peroxide is that of the oxidized intermediate.
The spectral changes are not as large as those observed when wild-type CcP reacts with
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hydrogen peroxide, Figure 3.1, but there are some aspects of the spectral change that suggest at
least partial formation of an Fe(IV) intermediate.

There is a slight red-shift of the Soret

maximum from 406 to 408, but the maximum increase in absorbance occurs at 426 nm (lower
panel Figure 3.19) similar to the maximum absorbance increase at 424 nm for the reaction
between wild-type CcP and hydrogen peroxide, Figure 3.1.
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Figure 3.19: Spectrum of CcP(H175C/D235L) in the presence H2O2. (Upper Panel - Spectrum
of the free mutant (solid line), spectrum of the mutant within 10 s of mixing with a
stoichiometric amount of H2O2 (dashed line), and spectrum of the mutant 24 hours after mixing
with stoichiometric H2O2 (dashed-double dotted line). Lower Panel – difference spectrum
between the initial product of the H2O2 reaction and the free mutant).
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The largest change in absorbance upon mixing the H175C/D235L CcP mutant is the
decrease in absorbance in the δ band at 388 nm. This is typical for the conversion of a pentacoordinate heme to a hexa-coordinate form such as the oxyferryl, Fe(IV) group.
The third spectrum included in Figure 3.19 is the sample of CcP(H175C/D235L) with
the stoichiometric addition of H2O2 after it had reacted for 24 hours (dash-double dotted line).
The sample does not return to the Fe(III) form of CcP(H175C/D235L) but rather shows a
decrease in the intensity of the Soret and visible bands suggesting oxidative degradation of the
heme. It appears as if the heme in the CcP(H175C/D235L) mutant is more susceptible to
oxidative degradation than is the heme in the wild-type enzyme.
The rate of the initial absorbance change at 390 nm, attributed to Compound I formation,
was investigated using stopped-flow techniques. Figure 3.20 shows the decrease in absorbance
at 390 nm as a function of time upon mixing hydrogen peroxide and CcP(H175C/D235L). The
initial reaction is complete within about 0.2 seconds with an observed rate constant of 14.9 ± 0.4
s-1 using 10.3 µM H2O2. The rate of Compound I formation was determined as a function of the
hydrogen peroxide concentration.

The observed rate constants at pH 6 are plotted versus

hydrogen peroxide concentration in Figure 3.21. The observed rate constants were fit to a linear
equation using weighted linear least-squares regression, where the slope yields a bimolecular rate
constant for Compound I formation, k1. The best-fit value for k1 is (1.2 ± 0.1) x 106 M-1 s-1. The
rate of formation of Compound I for the CcP(H174C/D235L) mutant is about 1.6 orders of
magnitude smaller than that of rCcP, which is (4.8 ± 0.2) x 107 M-1s-1.
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Figure 3.20: Reaction of CcP(H175C/D235L) with H2O2. (The data were fit to a single
exponential decay reaction with observed rate constant equal to 14.9 ± 0.4 s-1. Experimental
conditions: [CcP(H175C/D235L)] = 1.06 µM, [H2O2] = 10.3 µM, pH 6.0, 0.100 M ionic
strength potassium phosphate buffer, 25 ºC).
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Figure 3.21: k1obs as a function of [H2O2]. (The best-fit value for the slope of the plot is (1.2 ±
0.1) x 106 M-1s-1).
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Heme Degradation

The heme group in CcP(H175C/D235L) appears to be more susceptible to oxidative
degradation by hydrogen peroxide than wild-type CcP. The spectral changes shown in Figure
3.19 show that there is a permanent decrease of 16% in the absorptivity at the Soret maximum
upon mixing stoichiometric amounts of CcP(H174C/D235L) and hydrogen peroxide and
allowing the reaction to proceed for 24 hours. Under comparable conditions, the Soret maximum
in wild-type CcP decreases 6% [53].
In Figure 3.22, the oxidative degradation of the heme group in CcP(H175C/D235L) was
followed at 424 nm after the addition of a stoichiometric amount of hydrogen peroxide.
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Figure 3.22:
Oxidative degradation of the heme in CcP(H175C/D235L) by H2O2.
(Experimental conditions: 12.2 µM H2O2, 12.0 µM CcP(H175C/D235L)).
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The absorbance change is biphasic and was fit to a two-exponential function, using nonlinear least squares regression. Best-fit values for the observed rate constants are: kd1 = (5.3 ±
0.4) x 10-3 s-1 and kd2 = (8.8 ± 0.6) x 10-5 s-1. Both rates are comparable to the decay rates of
rCcP Compound I, Table 3.4.

Hydroxylation Activity of CcP and CcP Mutants

Although we were able to show that CcP Compound I could directly oxidize acrylonitrile
in a peroxygenase reaction, we were unable to use this method to monitor the peroxygenase
reactions of the four CcP mutants under investigation in this study. After the conclusion of the
original study and while this thesis was being written, Watanabe and coworkers developed a
simple colorimetric assay to measure the hydroxylation activity of a naphthalene derivative [17].
Hydroxylation of apolar organic substrates is a typical reaction for monooxygenases and
peroxygenases and we decided to test the peroxygenase activity of CcP and the CcP triple
mutants using the Watanabe protocol.
methoxynaphthalene.

The substrate in the Watanabe protocol is 1-

Hydroxylation of 1-methoxynaphthalene leads to the formation of a

pigment called Russig’s blue, from which the hydroxylation rate can be determined.

The

mechanism of Russig’s blue formation was presented in Chapter 1.

Hydroxylation Activity of the CcP Triple Mutants

In collaboration with Dr. James Erman (Northern Illinois University), the peroxygenase
activity of CcP and the three CcP triple mutants was investigated using 1-methoxynaphthalane as
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a substrate. The CcP(triAla) catalyzed oxidation of 1-methoxynaphtalene by hydrogen peroxide
at pH 7.0 is shown in Figure 3.23.
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Figure 3.23: CcP(triAla)-catalyzed oxidation of 1-methoxynaphthalene by H2O2. (Spectra were
collected every minute for one hour after addition of H2O2. Inset – Increase in the absorbance at
610 nm as a function of time after H2O2 addition. Experimental Conditions: [CcP(triAla)] = 2.0
µM, [1-methoxynaphthalene] = 0.50 mM, [H2O2] = 1.00 mM, pH 7.0, 0.100 M ionic strength
potassium phosphate buffer, 25 ºC).

There is a large increase in the absorbance between 450 and 800 nm due to the formation
of Russig’s blue. The spectral scans of the CcP(triLeu), CcP(triVal) and rCcP catalyzed Russig’s
blue formation are similar to those for CcP(triAla). The inset of Figure 3.23 shows the increase
in absorbance at 610 nm as a function of time from which the initial velocity can be determined.
The initial velocity is given by Equation 3.7, where the factor of 2 is required since two
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molecules of 1-methoxynapthalene need to be hydroxylated in order to produce one molecule of
the Russig’s blue product.

V0 = 2(dA/dt)/Δε

(3.7)

The change in extinction coefficient, Δε, for Russig’s blue formation in aqueous solution
is 1.45 x 104 M-1 cm-1 at 610 nm, from which the change in absorbance can be converted to
concentration units.

The initial velocity increases linearly with increasing CcP(triAla)

concentration showing that CcP(triAla) is catalyzing Russig’s blue formation, Figure 3.24.
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Figure 3.24: Initial velocity for 1-methoxynapthalene hydroxylation as a function of enzyme
concentration. (CcP(triAla) – solid circles, CcP(triLeu) - open circles. Experimental conditions:
[1-methoxynaphthalene] = 0.50 mM, [H2O2] = 1.00 mM, pH 7.0, 0.100 M ionic strength
potassium phosphate buffer, 25 ºC).
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The slope of the plot in Figure 3.24 gives a turnover number of 0.150 ± 0.008 min-1 for
the CcP(triAla) hydroxylation activity. Also shown in Figure 3.24 is the initial velocity for the
CcP(triLeu)-catalyzed oxidation of 1-methoxynaphthalene as a function of the CcP(triLeu)
concentration.

The turnover number for the CcP(triLeu)-catalyzed hydroxylation of 1-

methoxynaphthalene is 0.134 ± 0.014 min-1.
Unlike CcP(triAla) and CcP(triLeu), the initial velocity for the CcP(triVal)-catalyzed
oxidation of 1-methoxynapthalene is independent of the CcP(triVal) concentration between 5
and 10 µM. A minimum value of 0.137 min-1 can be calculated for the CcP(triVal) turnover rate.
Wild-type rCcP is much less active than the apolar distal pocket mutants of CcP and has a
turnover number of 0.0043 ± 0.0003 min-1 for hydroxylation of 1-methoxynapthalene at the
standard reaction conditions. Turnover numbers for hydroxylation of 1-methoxynaphthalene by
rCcP and the CcP triple mutants are included in Table 3.5.
The rate of 1-methoxyhaphthalene hydroxylation catalyzed by CcP(triAla) was studied as
functions of the 1-methoxynaphthalene and hydrogen peroxide concentrations.

The initial

velocity increases linearly with 1-methoxynaphthalene concentration over the limited
concentration range available, less than 1 mM. The initial velocity also increases linearly with
hydrogen peroxide concentrations. Apparent second-order rate constants for the interaction of 1methoxynaphthalene with CcP(triAla) Compound I and of hydrogen peroxide with CcP(triAla)
are 1.5 ± 0.2 M-1s-1 and 1.1 ± 0.1 M-1s-1, respectively.
At the high concentrations of hydrogen peroxide used in the Russig’s blue assay,
significant bleaching of the Soret absorption band occurs during the reaction.

Note the

significance decrease in absorbance in the Soret region in Figure 3.23 during the Russig’s blue
assay. The destruction of the heme in the CcP during the hydroxylation reaction diminishes the
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effectiveness of CcP and its mutants as peroxygenation catalysts.

In one study of the

hydroxylation of 1-methoxynaphthalene catalyzed by CcP(triAla), the formation of Russig’s blue
was followed until cessation of the reaction. Cessation of the reaction was due to inactivation of
the catalyst rather than depletion of the reactants. Using 10 µM CcP(triAla) in the standard
reaction assay, 19.5 µM Russig’s blue was formed, corresponding to the hydroxylation of 39 µM
1-methoxynaphthalene. Only 3.9 catalytic cycles were completed before complete inactivation
of the enzyme. In addition to increasing the rate of hydroxylation, construction of an effective
peroxygenase will require development of catalysts that are more resistant to oxidative
degradation of the heme group by hydrogen peroxide.

Table 3.5. Peroxygenase Activity of CcP and CcP Mutants.
Enzyme

Substrate

Substrate
Concentration
(mM)

pH

TN
(min-1)

rCcP

acrylonitrile

5.0

6.0

0.0025 ± 0.0007

rCcP

acrylonitrile

saturating

6.0

0.61 ± 0.18

rCcP

styrene

5.0

6.0

0.00014

yCcP

trans-β-methylstyrene

5.0

7.0

0.012 α

yCcP

cis-β-methylstyrene

5.0

7.0

0.017 α

rCcP

1-methoxynaphthalene

0.50

7.0

0.0043 ± 0.0003

CcP(triAla)

1-methoxynaphthalene

0.50

7.0

0.150 ± 0.008

CcP(triVal)

1-methoxynaphthalene

0.50

7.0

>0.137

CcP(triLeu) 1-methoxynaphthalene

0.50

7.0

0.134 ± 0.014

a

[22].
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Screening of CcP Mutants and Other Heme Proteins for Hydroxylation Activity

The Russig’s blue assay is so facile that members of the Erman-Vitello laboratory
screened all of the CcP heme pocket mutants that were available in the laboratory as well as four
other heme proteins, Glycera dibranchiate hemoglobin and the heme domains of three heme
sensor proteins, the direct oxygen sensor in Escherichia coli (EcDOSH) and the FixLs from
Sinorhizobium meliloti (SmFixLH) and Bradyrhizobium japonicum (BjfixLH). The results are
shown in Figure 3.25.
Of the 25 proteins screened for 1-methoxynaphthalene hydroxylation activity, the three
CcP triple mutants had the highest activity, with CcP(triAla) almost 35-times more active than
rCcP. Interestingly, the CcP(H175C/D235L) mutant is one of the less active mutants even
though it was designed to have the same type of heme ligation as the cytochrome P450s. The
least active protein was SmFixLH, which had an apparent negative activity. The apparent
negative activity means that the blank reaction for the increase in absorbance at 610 nm in the
presence of 1 mM H2O2 is faster in the absence of 1-methoxynaphthalene than in its’ presence.
In addition to the hydroxylation activity, it is also easy to measure the heme degradation
during the Russig’s blue assay by noting the decrease in the Soret absorbance during the assay.
Figure 3.26 shows the percent of Soret intensity remaining after 30 minutes of the Russig’s blue
assay.
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Figure 3.25: Turnover rates, v0/e0, for the Russig’s blue assay. (The heme proteins screened are
rCcP, 20 CcP heme pocket mutants, Glycera dibranchiate hemoglobin (Glycera Hb) and the
heme domains of three heme sensor proteins, the direct oxygen sensor in Escherichia coli
(EcDOSH) and the FixLs from Sinorhizobium meliloti (SmFixLH) and Bradyrhizobium
japonicum (BjfixLH). Standard reaction conditions: [1-methoxynaphthalene] = 0.50 mM,
[H2O2] = 1.00 mM, pH 7.0, 0.100 M ionic strength potassium phosphate buffer, 25 ºC).
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Figure 3.26: Heme degradation during the hydroxylation of 1-methoxynaphthalene. (The
percentage of the maximum Soret absorbance remaining after 30 minutes of the hydroxylation
assay is plotted for each of the proteins listed in Figure 3.25).
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Heme destruction under the conditions of the Russig’s blue assay is quite variable.
Glycera Hb is most susceptible to heme destruction with only 24% of the Soret absorbance
remaining after the assay while CcP(H52N) is the most stable, with less than 8% of the heme
degraded during the reaction. Development of an efficient peroxygenase will require optimizing
both the oxygen transfer activity of the enzyme as well as optimizing the stability of the heme
group toward oxidative degradation by H2O2. CcP(triLeu) may be the best candidate for further
development of an efficient peroxygenase. It is the third most active catalyst, only 11% less
active than CcP(triAla), and the fifth most resistant to heme degradation, with 74% of the Soret
absorbance remaining at the end of the assay.

CHAPTER FOUR
DISCUSSION

Oxygenase vs Peroxygenase Reactions

Monooxygenases catalyze the oxidation of a wide variety of organic substrates utilizing
O2, by incorporating one of the oxygen atoms into the organic substrate and reducing the second
to water. The cytochrome P450s are a versatile class of monooxygenases present in many
species including plants, fungi, bacteria, insects, and mammals [12]. In mammals, the P450s aid
in the metabolism of xenobiotics and in steroid hormone biosynthesis. Activities of P450s
include hydrocarbon hydroxylation, olefin epoxidation, heteroatom oxygenation, dealkylation of
ethers, thioethers, and substituted amines, desaturation at isolated carbon-carbon bonds, and
aldehyde deformylation [13]. Due to the abundance of activities, multiple P450s can be found in
the same organism. This thesis has focused on three P450 activities, the epoxidation of styrene,
the epoxidation of acrylonitrile, and the hydroxylation of 1-methoxynaphthalene.
The high degrees of chemo-, regio-, and stereo-selectivity of the P450-catalyzed reactions
have made them targets for use in synthetic organic chemistry, including industrial scale
synthesis [2]. There are several problems with the use of P450s in industrial catalysis. The first
is that P450 oxygenase reactions are typically slow. Liver microsomal P450s generally catalyze
oxygenation reactions with rates on the order of approximately 1 min-1. On the other hand,
bacterial P450s have rates that can be on the order of 103 min-1 [14-16]. The second problem in
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the use of P450s as industrial catalysts is that the reduction of O2 is a four electron reaction and
requires the use of a cofactor, NAD(P)H, to provide two electrons for the reaction. A second
enzyme, cytochrome P450 reductase, is also required to catalyze the electron transfer from
NAD(P)H to the P450. The need for a cofactor and additional enzyme adds to the complexity
and cost of the process. Finally, the P450s are not robust catalysts, since they are susceptible to
oxidative degradation during the catalytic cycle.
In order to improve the P450 oxygenase reaction system, mutagenesis of bacterial P450s
has been investigated.

For example, Arnold and colleagues, have developed a mutant of

cytochrome P450 BM-3 designated mutant 139-3, which has an initial rate of styrene oxide
formation of 385 min-1, about 13-fold higher than the wild-type enzyme and the highest turnover
rate yet reported for the P450 styrene epoxidation reaction [54, 55]. Cytochrome P450 BM-3 is
an interesting enzyme in that it has evolved to include both the P450 reaction site as well as the
P450 reductase activity. A separate cytochrome P450 reductase is not required with P450 BM-3
although the NAD(P)H cofactor is still required.

Wong and co-workers, have engineered

bacterial P450cam mutants at the Y96 residue to increase the number of oxidizable substrates
[56]. The Y96F mutant of cytochrome P450cam, has a naphthalene hydroxylation rate of 100
min-1, a 140-fold increase in the hydroxylation of the wild-type enzyme. Mutagenesis appears to
be a feasible way to increase the rate of specific monooxygenase reactions, but these systems,
except for P450 BM-3, still require use of a reductase and all require a NADH or NADPH
cofactor [54].
Peroxygenase reactions, on the other hand, utilize hydrogen peroxide to catalyze
oxidative reactions. This eliminates the need for the electron donating NAD(P)H cofactor
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required for the oxygenase reactions. This route is referred to as the “peroxide shunt” pathway,
Equation 4.1.

S + H2O2 → SO + H2O

(4.1)

Peroxygenase reactions are atypical reactions that are generally slower than the
oxygenase reactions. The P450 enzymes appear to be more susceptible to oxidative degradation
in the presence of H2O2 than in the presence of O2. Attempts have been made to improve upon
the peroxygenase activity of P450s in order to make them synthetically viable in vitro. Arnold
and colleagues reported that through the directed evolution of the P450 from Pseudomonas
putida, mutants were created that hydroxylate naphthalene with a 20-fold higher activity than the
native enzyme, although absolute rates were not given [3]. In a later paper, the Arnold group
reported that a mutant of cytochrome P450 BM-3, designated 21B3, catalyzed the H2O2
oxidation of styrene to produce styrene oxide at a rate of 54 min-1, higher than the
monooxygenase activity of 30 min-1 for this enzyme [55]. Further evolution of the P450s may
improve upon the activity of the peroxide shunt pathway possibly making them more
commercially viable.
Several researchers have utilized other heme protein platforms to develop peroxygenase
enzymes. Most of the studies have utilized styrene epoxidation as the test reaction. Matsui et
al., have shown that the H64D mutant of sperm whale metmyoglobin can oxidize styrene with an
initial rate of 18 min-1, an 800-fold increase over the peroxygenase activity of the wild-type
protein of 0.022 min-1 [24]. Smith and Ngo have shown that the H42/F41A/R38H mutant of
horseradish peroxidase increases the rate of styrene peroxygenation by a factor of 1.3 x 10 4, from
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a rate of 6 x 10-4 min-1 for wild-type horseradish peroxidase to a rate of 7.6 min-1 for the mutant
[57]. Additionally, chloroperoxidase and its C29H (proximal cysteine) mutant have styrene
peroxygenation rates of 290 and 220 min-1, respectively [58].
The Erman/Vitello laboratory has a long history of investigating the properties of CcP
and a large number of CcP mutants in order to further understanding of structure/function
relationships in heme proteins. In addition, CcP Compound I is very stable and resistant to heme
degradation, which should make it an ideal platform on which to develop peroxygenation
catalysts [34]. CcP has been shown to have an open active site by Ortiz de Montellano and
colleagues [22]. CcP will react with phenylhydrazine to form a phenyl-iron complex, suggesting
that the iron in the heme active site is accessible to small organic substrates. Ortiz de Montellano
and co-workers have also created a W51A mutant of CcP where the bulky tryptophan side chain
in the active site is replaced by a methyl group. Both recombinant CcP and the CcP(W51A)
mutant oxidize thioanisole to the sufloxide and catalyze the epoxidation of styrene, trans-β–
methylstyrene, and cis-β-methylstyrene by hydrogen peroxide under steady-state conditions
using 5 mM styrene and between 0.1 and 1.0 mM H2O2. The turnover numbers are 0.012 min-1
and 0.017 min-1 for the oxidation of the trans and cis isomers, respectively. These rates are
about 10 times slower than cytochrome P450. Therefore, it has already been shown that CcP can
catalyze monooxygenation-type reactions utilizing H2O2, if the heme iron is accessible to the
substrate.
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Peroxygenase Activity of CcP

Reduction of CcP Compound I in the Presence of Styrene

Since Ortiz de Montellano and colleagues have shown that CcP and a CcP mutant,
(W51A), have low levels of peroxygenase activity, we investigated the transient-state reaction
between preformed CcP Compound I and styrene [22]. We found that adding up to 6 mM
styrene to CcP Compound I had very little effect on the endogenous reduction of the Fe(IV) site
in CcP Compound I, (Figure 3.8). The plot of the reduction rate of Compound I as a function of
styrene concentration has a slope of (4.6 ± 4.1) x 10-4 M-1 s-1. This apparent bimolecular rate
constant between CcP Compound I and styrene gives an apparent turnover number of (1.4 ± 1.2)
x 10-4 min-1 using 5 mM styrene, about two-orders of magnitude slower than the steady-state
activities reported by Ortiz de Montellano. The steady-state oxidation of styrene observed by
Ortiz de Montellano may go through a different mechanism. The co-oxidation mechanism he
and colleagues proposed for myoglobin, where a protein radical generated from H2O2 migrates to
the surface of the protein and interacts with molecular oxygen incorporating one of the O 2 atoms
into the organic substrate is a likely alternative mechanism [42].

Reduction of CcP Compound I in the Presence of Acrylonitrile

The reduction of CcP Compound I by acrylonitrile is slow, but tenfold faster than
reduction by styrene, and competes with the endogenous reduction of the oxidized sites in CcP
Compound I. At low acrylonitrile concentrations, the reduction of Compound I is similar to that
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of the endogenous reduction of CcP Compound I.

When acrylonitrile concentrations are

increased, the reduction of Compound I is significantly faster than the endogenous reduction,
(Figure 3.4), indicating that acrylonitrile does reduce Compound I and is, in turn, oxidized by
Compound I to the epoxide in a single two-electron redox reaction.

CcPI + acrylonitrile  CcP + epoxide

Linear–least squares analysis of the data, (Figure 3.5), gives an apparent bimolecular rate
constant for the CcP Compound I acrylonitrile reaction of (4.3  0.3) x 10-3 M-1 s-1. Diana
Chinchilla has previously shown that acrylonitrile binds to the heme iron with an equilibrium
dissociation constant of 1.2 ± 0.3 M [25]. Fitting the CcP Compound I reduction rate in the
presence of acrylonitrile to a hyperbolic binding equation gives a maximum turnover number of
0.61 min-1.
No studies have been reported of acrylonitrile oxidation via the “peroxide shunt” pathway
with the cytochrome P450s but these rates are typically slower than the monoxygenase rates for
the same substrates. The maximum turnover rate for the CcP-catalyzed oxidation of acrylonitrile
by hydrogen peroxide, 0.61 min-1, is within the range of the monoxygenase rates reported for
microsomal preparations. Microsomal preparation turnover rates vary over a large range, from
1.3 x 10-4 min-1 for cytochrome P450-2E1 to 4.9 min-1 for acetone-treated rat liver microsomal
preparations [36, 40].
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Development and Characterization of CcP Mutants with Peroxygenase Activity

A major problem in developing CcP as a peroxygenase catalyst is that the distal heme
pocket is very polar with a protonated arginine residue and the distal histidine in the pocket,
(Figure 1.6). Initial thinking led to making the pocket more nonpolar so that apolar organic
substrates would bind preferentially within the heme pocket.

Three triple mutants were

developed in which Arg-48, Trp-51, and His-52 were simultaneously mutated to either all
alanines, all valines, or all leucines, generating the mutants designated as CcP(triAla),
CcP(triVal), and CcP(triLeu). A fourth mutant was developed in the laboratory of Professor Yi
Lu at the University of Illinois, Urbana-Champaign. CcP(H175C/D235L) simulates the axial
ligation of the cytochrome P450, which some consider as a key component in the differential
reactivity of the P450s and the peroxidases.

Professor Lu and colleagues determined the

spectroscopic properties of this mutant and provided us with a sample to determine its’
peroxidase activity, reaction with H2O2, and to test its’ peroxygenase activity [16].

Spectroscopic Properties of rCcP, CcP(triAla), CcP(triVal), and CcP(triLeu)

CcP and its’ mutants are generally stable between pH 4 to 8. The spectra of rCcP and the
three apolar mutants show dependence upon pH indicating changes in heme-iron coordination
with changes in pH. All heme proteins have four absorption bands attributed to the heme
designated as the α, β, γ (Soret), and δ bands. In addition to these bands, high-spin ferric heme
proteins have two additional ligand-to-metal charge transfer bands labelled as CT1 and CT2.
The location of these bands and the extinction coefficients reveal the spin and coordination state
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of the heme group, (Figures 3-9, 3-10, and 3-11). The extinction coefficients (in the Soret
region) of all three mutants have a bell-shaped dependence on pH revealing that the spectra are
influenced by a minimum of two acid/base transitions, (Figure 3-12).
CcP and the three mutants are in their most stable form at pH 6, the middle of the pH
stability range. The Soret bands of the three mutants, (Table 3.2) are all at shorter wavelengths
than 408 nm, which is the location of the Soret band of recombinant CcP. The intermediate
position of the δ band and the indistinct CT1 and CT2 bands indicate that the heme group in all
three mutants are a mixture of five and six coordinate forms with a small amount of low-spin
heme iron.
Due to the onset of acid denaturation, at pH 4, the Soret bands of all three mutants
undergo a blue-shift compared to the positions at pH 6. The maximum absorptivity in the Soret
band decreases at pH 4 in comparison to the maximum absorptivity at pH 6 and the CT1 band is
red-shifted and more distinct. This reveals that the heme group of all three mutants is in the five
coordinate high-spin form.

The five coordinate heme in CcP(triVal) in more pronounced

because the Soret band is very broad.
As the pH is raised above pH 6, there is a red shift of the Soret band, loss of absorption in
CT1 and CT2, and the β band dominates the spectrum of the three mutants. This shows that the
three mutants convert to six coordinate low-spin, with hydroxide as the most probable ligand at
pH 8.
The spectrum of CcP(H175C/D235L), (Figure 3.19), has its Soret band at 406 nm,
similar to that of wild-type CcP and consistent with a more polar heme pocket. The large
extinction coefficient of the δ band and the prominent charge-transfer bands are consistent with a
five-coordinate, high-spin heme.
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Reaction with Hydrogen Peroxide to Form Compound I

Recombinant CcP (rCcP) reacts rapidly with hydrogen peroxide with a bimolecular rate
constant of (4.8 ± 0.2) x 107 M-1s-1 [48]. By replacing all three distal residues of CcP with apolar
groups, the rate of formation and the stability of Compound I formation were altered as
compared to rCcP. All three mutants react differently with hydrogen peroxide.
The spectra of CcP(triAla) did not reveal any CcP Compound I-type intermediate with
the addition of hydrogen peroxide. Either the formation of a Compound I-type intermediate is so
slow that the rate of endogeneous reduction outstrips it so that the Compound-I-type intermediate
is not noticeable or the heme iron may homolytically cleave the peroxide oxygen-oxygen bond
producing two hydroxyl radicals which may lead to the rapid oxidative heme degradation.
In contrast to CcP(triAla), both CcP(triVal) and CcP(triLeu) spectra show a small initial
increase at 424 nm with the addition of hydrogen peroxide. This suggests CcP Compound I
formation. The rate of Compound I formation for CcP(triVal) is 20 ± 4 M-1s-1 and 170 ± 10
M-1s-1 for CcP(triLeu), (Table 3.4).

These k1 values are consistent with the steady-state

measurements. Both CcP(triVal) and CcP(triLeu) have k1 values that are six and five orders of
magnitude smaller than that of rCcP respectively, (4.8 ± 0.2) x 107 M-1s-1. This is consistent with
the study by Erman et al. which revealed that replacement of the distal histidine, His-52, with
apolar residues causes a five- to six-order of magnitude decrease in the rate of reaction with
H2O2 [44]. The residue His-52 functions as a base catalyst. It facilitates the ionization of
hydrogen peroxide within the distal heme pocket allowing the peroxide anion to bind to the heme
iron during formation of Compound I. Removal of this base catalyst decreases the formation of
Compound I thus allowing heme degradation to be the more predominant reaction.
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CcP(H175C/D235L) reacts with H2O2 with a bimolecular rate constant of (1.2 ± 0.1) x
106 M-1s-1, about 35-times slower than rCcP. The spectral changes upon reaction with H2O2 are
not large, Figure 3.19, but suggest at least partial formation of an Fe(IV) intermediate. There is
a slight red-shift of the Soret maximum from 406 to 408 nm, but the maximum increase in
absorbance occurs at 426 nm, similar to the maximum absorbance increase at 424 nm for the
reaction between wild-type CcP and hydrogen peroxide. The largest change in absorbance upon
mixing the CcP(H175C/D345L) mutant is the decrease in absorbance in the δ band at 388 nm.
This is typical for the conversion of a penta-coordinate heme to a hexa-coordinate form such as
the oxyferryl, Fe(IV) group.

Endogenous Reduction of Compound I and Compound I-type Intermediates in the Mutants

CcP Compound I undergoes a biphasic endogenous reduction with rate constants of (1.8
± 0.1) x 10-3 s-1 and (3.0 ± 0.1) x 10-5 s-1, in the absence of a substrate such as ferrocytochrome c.
The fast phase of the endogenous reduction is attributed to the migration of the Trp-191 radical
away from the heme. The slow phase of the reaction is attributed to reduction of the Fe(IV)
heme to the Fe(III) state.
When H2O2 is added to CcP(triAla), instead of observing Compound I formation, the
heme appears to undergo irreversible oxidative degradation.

The rate of degradation is

monitored by observing the decrease in heme absorbance over time. The amount of heme
degradation is independent of the hydrogen peroxide concentration between 30 µM and 1 mM.
The reaction of all three triple mutants with 10 equivalents of H2O2 was also observed.
The reduction (heme degradation) rates for the triple mutants are comparable to those of native
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CcP Compound I endogenous reduction, (Table 3.4). However, the reactions of the triple
mutants are more complex than those of native CcP Compound I because they include significant
irreversible degradation of the heme.
Because the interaction of H2O2 and the triple mutants is so complex and the rate of
formation of any Compound-I-type intermediate so slow, we were unable to determine any
peroxygenase activity of the triple mutants by direct observation of reduction of Compound I as
we did for wild-type CcP.

1-Methoxynaphthalene Hydroxylation Activity

Studies on naphthalene hydroxylation by the cytochrome P450s are less common than
those of styrene epoxidation. Rat liver microsomes hydroxylate naphthalene with a turnover rate
of 0.32 min-1 [59]. Cytochrome P450cam hydroxylates naphthalene with a rate of 0.7 min-1 and
the fastest reported naphthalene hydroxylation rate of 100 min-1 was reported for an engineered
mutant of P450cam, Y96F [56]. Joo et al. have used laboratory evolution techniques to enhance
the peroxygenase activity of cytochrome P450cam [3]. By using a fluorescence technique to
monitor naphthalene hydroxylation, they screened approximately 200,000 random mutants of
cytochrome P450cam and were able to select a mutant that had 11-fold higher peroxygenase
activity than did the wild-type enzyme. Unfortunately, turnover rates were not published.
The Russig’s blue assay of Watanabe et al. allows turnover rates to be determined for the
hydroxylation of 1-methoxynaphthalene utilizing hydrogen peroxide [17]. They investigated
three heme proteins for peroxygenase activity, cytochrome P450BSβ, HRP, and myoglobin.
Cytochrome P450BSβ is a naturally-occurring peroxygenase, which hydroxylates fatty acids
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predominantly at the β position [19]. It has no monooxygenase activity and does not react with
hydrogen peroxide in the absence of the fatty acid substrate. Myristic acid is the preferred
substrate and the turnover rate is about 300 min-1. In the presence of a short-chain fatty acid,
cytochrome P450BSβ will catalyze the peroxygenation of a variety of nonnatural substrates such
as styrene, ethylbenzene, and 1-methoxynaphthalene. Turnover rates for styrene epoxidation and
1-methoxynaphthalene hydroxylation are 330 and 112 min-1, respectively. HRP has no
detectable activity in the Russig’s blue assay while wild-type sperm whale myoglobin has a
turnover number of approximately 0.03 min-1. The H64A mutation of myoglobin increases the
rate of Russig’s blue formation almost 800-fold to 23 min-1.
We have investigated the enzyme-catalyzed hydroxylation of 1-methoxynaphthalene by
hydrogen peroxide using the Russig’s blue assay for rCcP, 20 mutants of CcP, Glycera Hb, and
the heme domains of three heme sensor proteins, EcDOSH, SmFixLH, and BjfixLH (Figure
3.25). rCcP has detectable hydroxylation activity with a turnover number of 0.0043 min-1. rCcP
has greater activity than HRP but a lower activity than sperm whale myoglobin and cytochrome
P450BSβ . The three CcP mutants designed to have apolar distal heme pockets to promote
partitioning of non-polar substrates into the heme pocket (CcP(triAla), CcP(triVal), and
CcP(triLeu)) have the highest hydroxylation activity, increasing about 30-fold compared to rCcP.
None of the other screened proteins were as active as the CcP(triAla), CcP(triVal), and
CcP(triLeu) mutants. However, there were some interesting results.
The peroxygenase activity of Glycera Hb is identical to that of rCcP while the activity of
BjFixLH is twice that of rCcP. On the other hand, SmFixLH has no detectable peroxygenase
activity, in fact, the decrease in absorbance at 610 nm was faster in the presence of
1-methoxynaphthalene than in its absence giving a negative v0 value for SmFixLH. Two CcP
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mutants, H175C and H175C/D235L, simulate the heme ligation in cytochrome P450 but have
peroxygenase activities that are intermediate between those of rCcP and CcP(triAla).
Unfortunately, in the Russig’s blue assay we recorded rapid heme degradation (Figure
3.26). CcP(triAla) was completely inactivated within four catalytic cycles being one of the most
prone to heme degradation. For the twenty CcP mutants screened in this study, there is about a
10-fold variation in heme degradation during the Russig’s blue assay. CcP(H52N) is the most
stable with only 8% heme degradation while CcP(W51H) is the most susceptible mutant with
74% heme degradation. The degradation of the heme does not correlate with either the rate of
Compound I formation or the rate of 1-methoxynaphthalene hydroxylation. It is possibly due to
a secondary oxidation of the hydroxylated product within the distal heme pocket, producing
substrate-based radicals, which then react with the heme leading to the degradation.

Conclusions

Heme, with its central iron atom, can participate in a variety of ligand binding and
oxidation-reduction reactions. By embedding the heme group within different protein scaffolds,
organisms can channel the intrinsic heme reactivity to allow this class of proteins to perform a
wide variety of essential functions within the organism. In theory, any heme protein could be
modified in such a way that would allow it to change functionality. In this thesis, we have taken
some initial steps in probing the intrinsic reactivity of CcP with respect to its peroxygenase
activity.
We were unable to confirm the styrene epoxidase activity of CcP first reported by Ortiz
de Montellano and colleagues by direct observation of the oxidation of styrene by CcP
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Compound I [22]. We suggest that this could mean that the steady-state oxidation of styrene
observed by Ortiz de Montellano may go through a different mechanism, perhaps by the cooxidation mechanism he reported for horseradish peroxidase. Where H2O2 generates a protein
based radical that migrates to the proteins surface. The protein radical then interacts with
molecular oxygen and incorporates one of the O2 atoms into the organic substrate [42].
Compound I of CcP is unique among the peroxidases in that it contains a tryptophan radical
rather than a porphyrin radical and this type of mechanism needs to be considered.
In the case of acrylonitrile, CcP Compound I appears to directly oxidize this substrate to
the epoxide by transfer of the oxygen atom from the oxyferryl group in Compound I to the
substrate. The maximum rate for this transfer of 0.61 min-1 is similar to the rates of rat liver
microsomal cytochrome P450-catalyzed oxidation of acrylonitrile in the monoxygenase reaction.
The monooxygenase turnover rates vary over a very large range for the P450s, varying from 1.3
x 10-4 min-1 for cytochrome P450-2E1 [40] to 4.9 min-1 for acetone-treated rat liver microsomal
preparations [36].
We

have

characterized

four

CcP

mutants

in

their

ability to

hydroxylate

1-methoxynaphthalene. Three of the mutants were developed in the Erman/Vitello laboratory,
CcP(triAla), CcP(triVal), and CcP(triLeu). These mutants generate an apolar distal heme pocket
at the expense of Arg-48 and His-52, two critical residues for the rapid formation and stability of
CcP Compound I. These three mutants enhance the hydroxylase activity of CcP by at least a
factor of 30 but the turnover numbers of 0.13 to 0.15 min-1 are still significantly smaller than
those for the monooxygenase activity of some bacterial P450’s with rates of 103 min-1 [1, 14,
15]. The fourth mutant, CcP(H175C/D235L), was developed in the laboratory of Professor Yi Lu
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to mimic cytochrome P450 heme coordination.

This mutant had a smaller naphthalene

hydroxylation rate than the three mutants with the apolar heme pockets.
A complicating factor in developing robust peroxygenation catalysts is that wild-type
CcP and all of the CcP mutants were significantly less stable with regard to heme degradation
during the hydroxylation reaction than was wild-type CcP in the absence of an oxidizable
substrate.

The stability of CcP Compound I toward heme degradation in the absence of

oxidizable substrates was one of the reasons initially used to consider CcP as a scaffold for
developing peroxygenation catalysts. Further development of CcP mutants as peroxygenase
reaction catalysts will need to maintain the stability of the enzyme while increasing the rate of
substrate turnover.
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